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Summary 
Multiple studies have examined antimicrobial susceptibility in bacteria from 
aquacultured products microorganisms and their environment. However, no information is 
available concerning antimicrobial resistance in bacterial flora of fish and seafood available 
at the retail level in Canada. This is particularly true for the common aquatic commensals, 
Aeromonas and Vibrio, for which some species are known zoonotic pathogens. In the 
course of this study, the antimicrobial susceptibility among Aeromonas spp. and Vibrio spp. 
from domestic and imported fish and seafood was characterized. Aeromonas and Vibrio 
spp. isolates cultured from finfish and shrimp samples were evaluated for antimicrobial 
susceptibility by broth microdilution and/or disk diffusion techniques. Antimicrobial 
classes examined in detail included: tetracyclines (TET), folate pathway inhibitors 
(sulfadimethoxine-trimethoprim, SXT), florfenicol (FLO), and the quinolones (nalidixic 
acid / enrofloxacin, NA/ENO). Epidemiological cut-off values (ECV’s) for 
Aeromonas/Vibrio were established using normalized resistance interpretation (NRI) of 
disk diffusion data. Isolates were further examined by PCR and microarray for genes 
associated with their antimicrobial resistance. Of 201 Aeromonas and 185 Vibrio isolates, 
those classified as resistant were as follows, respectively: TET (n=24 and 10), FLO (n=1 
and 0), SXT (n=2 and 8), NA (n=7 and 5) and ENO (n=5 and 0). Various combinations of 
tet(A), tet(B), tet(E), floR, sul1, sul2 and intI1 genes were detected with tet(E), intI1, sul2 
and tet(B) being the most common. Vibrio and Aeromonas species isolated from retail fish 
and seafood sources can harbor a variety of resistance determinants, although their 
occurrence is not high. The risk represented by these resistances remains to be evaluated in 
view of the potential for bacterial infection and their role as a reservoir for antimicrobial 
resistance. 
 
Key words: Aeromonas, Vibrio, antimicrobial resistance, normalised resistance 
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iv 
 
Résumé 
Plusieurs études ont examiné la sensibilité aux antimicrobiens chez les bactéries 
d’organismes provenant de produits issus de l’aquaculture ou de leur environnement.  
Aucune information n’est cependant disponible concernant la résistance aux antimicrobiens 
dans les bactéries de la flore de poissons ou de fruits de mer vendus au détail au Canada. 
C’est particulièrement vrai en ce qui a trait aux bactéries des genres Aeromonas et Vibrio, 
dont certaines espèces sont des agents pathogènes zoonotiques connus. Au cours de cette 
étude, la sensibilité aux antimicrobiens d’isolats d’Aeromonas spp. et de Vibrio spp. 
provenant de poissons et de crevettes domestiques et importés a été mesurée à l’aide de 
techniques de micro dilution en bouillon et/ou de diffusion sur disque. Les classes 
d’antimicrobiens examinés comprenaient les tétracyclines (TET), les inhibiteurs de la voie 
des folates (sulfadiméthoxine-triméthoprime, SXT), le florfenicol (FLO), et les quinolones 
(acide nalidixique / enrofloxacine, NA/ENO).  Des valeurs seuils épidémiologiques pour 
Aeromonas et Vibrio ont été établies en utilisant la méthode d’interprétation normalisée des 
données de résistance provenant de diffusion sur disque. La recherche de gènes de 
résistance associés au profil de résistance des isolats a été effectuée en utilisant des PCRs et 
des puces ADN.  Le nombre d’isolats résistants aux divers antimicrobiens parmi les 201 
isolats d’Aeromonas et les 185 isolats de Vibrio étaient respectivement les suivants: TET 
(n=24 et 10), FLO (n=1 et 0), SXT (n=2 et 8), NA (n=7 et 5) et ENO (n= 5 et 0). Diverses 
associations de gènes tet(A), tet(B), tet(E), floR, sul1, sul2, et intI1 ont été détectées, les 
gènes tet(E), intI1, sul2 et tet(B) étant les plus communs. Les espèces d’Aeromonas et de 
Vibrio isolées de poissons au détail et de fruits de mer peuvent héberger une variété de 
gènes de résistance, bien que peu fréquemment. Le risque que représente ces gènes de 
résistance reste à évaluer en considérant le potentiel infectieux des bactéries , l’utilisation 
des ces agents antimicrobiens pour le traitement des maladies en aquaculture et en 
médecine humaine et leur rôle en tant que réservoir de la résistance antimicrobienne. 
 
Mots-clefs:  Aeromonas, Vibrio, résistance aux antimicrobiens, normalised resistance 
interpretation (NRI), puce d’ADN, PCR, gènes de résistance 
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Introduction 
Aquaculture is the fastest growing animal production industry in the world. It is 
predicted that in the year 2020, worldwide demand will surpass the wild fisheries supply 
by 15-20% [1]. This would indicate that more fish will be produced in the aquaculture 
setting if supply is to meet the demand. Not only will the demand for seafood surpass the 
wild fisheries capacity, but the annual personal consumption of seafood is also expected to 
increase from 16 kg today to 31 kg in 2030 [2]. This would predict an increased human 
exposure to fish, seafood and their bacterial flora during the production, marketing and 
consumption activities. 
Aquaculture was in its infancy in Canada in the early 1980’s and now salmon 
growing operations on the East and West coasts of Canada compare favourably with other 
modern agriculture industries. Disease control is maintained with strict biosecurity 
measures as well as preventative measures such as vaccination, site fallowing/rotation and 
in certain cases, the judicious use of antimicrobials. Although antimicrobial exposure in the 
aquaculture setting is generally considered low as compared to other types of animal 
production, with an increase in consumption of aquacultured products as opposed to wild 
caught, there is a concomitant relative increase in the exposure to fish, seafood and their 
bacterial flora which possibly have had exposure to antimicrobials in an aquaculture 
setting. There are equally important differences in the regulations governing antimicrobial 
usage in agriculture (including aquaculture) depending upon the country examined. The 
availability of antimicrobials for use in aquaculture is extremely limited in North America 
where only three classes are available; tetracyclines, potentiated sulfa’s and phenicols. 
Although there are regulatory mechanisms to obtain antimicrobials without homologation, 
this is the exception rather than the rule. In other areas of the world such as in Asia, it is 
believed that antimicrobial usage is widespread and poorly regulated. Antimicrobial 
therapy in aquatic production is primarily administered orally whereas treatment by 
injection is reserved for highly valuable individuals such as broodstock. Therefore, in 
addition to the bacterial population causing disease, the bacterial flora on the fish and in 
the surrounding environment are equally exposed to the antimicrobials which evade 
consumption or their active metabolites secreted by the diseased organism. 
Resistance to antimicrobials in bacteria derived from aquacultured animals and/or 
the aquatic environment have been reported in numerous publications in the scientific 
literature [3]. In addition, there have been studies that indicate transmission of resistance 
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determinant between terrestrial and aquatic environments does take place [4, 5]. Multiple 
laboratory studies have also demonstrated that resistance determinants can be transferred 
between aquatic bacteria which are low pathogen risks to humans to Enterobacteriaceae 
for example [6-8]. If this exchange occurs, at what frequency it occurs, and how it occurs 
in the environment or in association with seafood has yet to be elucidated. 
It could reasonably be assumed that there is a certain level of risk of AMR exposure 
from aquatic bacteria pathogenic to humans, and from the transfer of resistance 
determinants from aquatic bacteria found on seafood and in the environment to bacteria 
pathogenic for humans, but the level of risk is unknown. The first step towards clarifying 
this question is examining and quantifying the presence of resistance elements in aquatic 
bacteria.  
Aeromonas and Vibrio are among the most common bacterial genera found on fish, 
shellfish and the aquatic environment. They are recognized pathogens of aquatic animals, 
causing economically important aquaculture diseases, as well as zoonotic pathogens 
capable of causing severe disease in humans. As such, there exists the possibility of the 
exposure of these genera to antimicrobials, and perhaps the development of resistance. In 
addition, they are easily cultivated on usual bacteriological media which is important when 
categorizing bacteria via standardized phenotypic AMR susceptibility testing methods. In 
this study, the prevalence of Aeromonas and Vibrio in retail seafood will be examined, as 
well as the prevalence of AMR and the genetic basis for the observed AMR phenotypes. 
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Review of the literature 
Vibrio and Aeromonas: pathogens of humans and animals 
Aeromonas and Vibrio species are Gram-negative, mobile, facultative anaerobic 
bacteria that are present in aquatic systems worldwide. Until 1986, Aeromonas and Vibrio 
species were found in the family Vibrionaceae. Following analysis of molecular genetic 
evidence by Colwell et al. in 1986, Aeromonas species were subsequently transfered to  a 
new family, the Aeromonadaceae [9]. There are currently 22 and 83 named species in the 
Aeromonas and Vibrio genera, respectively. Members of both genera are recognized as 
human and animal pathogens, and certain are zoonotic in nature. For details of the different 
species of this genera the following resources should be consulted [10, 11]. 
Vibrio species are predominantly halophilic and are therefore found more 
frequently in marine systems although certain species are reported in brackish and 
freshwater systems. They are among the most common bacteria isolated from marine 
molluscs and seafood [12, 13]. The Vibrio species anguillarum, ordalli, salmonicida, 
alginolyticus, and vulnificus are common pathogens of cultured marine fish causing 
septicaemia or focal chronic disease, the last two being zoonotic agents [14-17]. Vibrio 
vulnificus, Vibrio mimicus, Vibrio parahaemolyticus, Vibrio cholerae, are the species most 
often associated with disease in humans, and often in relation with consumption of raw or 
undercooked seafood, or in the case of V. cholerae, with fecal contamination of foodstuffs 
including water. The symptom most commonly encountered with Vibrio infections is 
gastroenteric upset, however in certain cases systemic disease may result, especially with 
V. vulnificus [18]. 
Aeromonas salmonicida as well as Aeromonas hydrophila and other motile 
Aeromonas species are also frequently found in fish, shellfish and other seafoods [19, 20].  
This genus is associated with severe acute septicemic and chronic disease in aquacultured 
animal species including salmonids and non-salmonids such as carp and frogs. Aeromonas 
in humans can cause serious disease including extra-intestinal infections such as 
bacteraemia, meningitis, pulmonary and wound infections although food poisoning and 
associated gastroenteritis is probably the most common sequel to exposure [16, 21, 22].  
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Importance of antimicrobial resistance 
Antimicrobial resistance (AMR) can be defined as the ability of microorganisms to 
resist the effect of an antibiotic or antimicrobial agent. This inefficacy of antimicrobials 
can be associated with intrinsic bacterial resistance, a mutation of the bacterial genome or 
by the acquisition of genetic material or a combination of these factors which will be 
discussed further on.  
The presence of antimicrobial resistance in a zoonotic species of either genera 
causing severe systemic disease may decrease the chances of successful therapy [23-27]. 
Although the spectre of outright therapeutic failure and mortality is the most feared 
outcome of antimicrobial resistance development, the impact of antimicrobial resistance on 
humans and animals is difficult to evaluate.  In human populations, increased levels of 
antimicrobial resistance have been associated with higher morbidity, mortality and 
increased hospitalization rates in the literature [28, 29]. This in turn may be explained by 
antimicrobial treatment failure or increased virulence of resistant bacterial strains, although 
the presence of pre-existing disease conditions and inadequate or delayed therapy may 
equally contibute [28, 30, 31]. Not all researchers agree however. Cosgrove (2006), 
Suneshine (2007) and Maragakis (2008) demonstrated an association between AMR and 
increases in mortality, morbidity and increased treatment costs whereas, conversely , 
Devasia et al. (2005) found no differences in treatment outcomes comparing patients 
infected with multi-drug-resistant ampC (MDR-AmpC) and pansusceptible Salmonella 
Newport [32]. The relationship between disease outcome and AMR is not clear cut . In 
addition to the health concerns, AMR represents a financial burden including direct costs 
such as hospitalisation for community acquired disease, increased hospital stay duration, 
prolonged therapy or changes to more costly medications, and repeat consulations [33].  
Estimates of the monetary cost of AMR in the United States have been pegged from 1.3 to 
5 billion dollars in the 1990’s [33, 34]. 
Antimicrobials are an important part of disease control in most animal production 
systems and are vital for cost effective production in treatment of episodic disease. They 
are used for infectious disease control/treatment, prevention of disease in high risk 
situations and for growth promotion [35]. Aquaculture differs in that the use of 
antimicrobials for growth promotion is not a current production practice. The use of 
antimicrobials in animal production, including aquaculture, has been fingered as an 
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important source of both resistant pathogenic and commensal bacteria [36, 37]. In 
aquaculture, there are multiple contributors to the development of resistance in aquatic 
bacteria which are likely similar to other agriculture production systems. Important factors 
include poor husbandry, lack of an accurate diagnosis followed by indiscriminate 
antimicrobial usage, repeated use of the same antibiotic, undiagnosed underlying disease 
processes, and inappropriate record keeping, [3].  
The most direct impact of non-susceptible bacterial pathogens in aquatic production 
is treatment failure. The availability of a limited number of antimicrobials approved for 
aquatic species; florfenicol (Aquaflor
®
), potentiated sulfas (Romet-30
®
 and Tribrissen
®
) 
and tetracyclines (Terramycin-Aqua
®
), at least in North America, exacerbates this 
situtation. Strains of Aeromonas salmonicida resistant to all of the aforementionned 
medications have been reported in fresh water aquaculture in Canada [38, 39]. The costs 
incurred by the presence of AMR in aquatic animal production are difficult to estimate 
although attempts have been made to model costs of disease in other species [40, 41]. In 
addition to the financial burden directly incurred through loss of stock via inefficacious 
treatments, the impact of medication costs, increased manhours needed for treatment 
activities (medication preparation and administration, removal of dead animals etc.), and 
fees charged by health professionals are also to be considered. 
Likely the most hotly debated issue of importance concerning AMR in 
agriculture/aquaculture is the impact on humans where the presence of antimicrobial 
resistance in a zoonotic species causing severe systemic disease may decrease the chances 
of successful therapy [23-27]. The danger that AMR development in animal production 
presents to humans is twofold. The first is the direct transmission of resistant human 
pathogens (eg. E. coli, Aeromonas sp. etc.) from animal to human, and the second is the 
contamination/infection by resistant commensal bacteria during manipulation or 
consumption somewhere along the food chain with a subsequent resistance gene 
transmission to human pathogens. Recent surveillance data generated by the Canadian 
Integrated Program for Antimicrobial Resistance Surveillance ( CIPARS ) program has 
furthered evidence of antimicrobial use and transmission of resistant bacteria by 
demonstrating trend associations between cephalosporin usage and resistant Salmonella in 
retail chicken [42]. Multiple laboratory studies have demonstrated that resistance 
determinants can be transferred between aquatic bacteria, which are low pathogen risks to 
humans (ex. Aeromonas salmonicida to Enterobacteriaceae) [6, 7, 43].  If this exchange 
6 
 
occurs, at what frequency it occurs, and how it occurs in the environment or in association 
with seafood has yet to be elucidated. Studies by Rhodes (2000) and Furushita (2003) 
make the argument that transmission of resistance determinants between terrestrial and 
aquatic environments does take place [4, 5]. Further, Rhodes (2000) suggests that aquatic 
and terrestrial environments should be considered as one interactive unit  [4]. If this is true, 
aquatic bacteria susceptibility will not only be affected by selective antimicrobial pressure 
on farm but from the availability of resistance determinants acquired from aquatic and 
terrestrial sources. 
Mechanisms of antimicrobial resistance 
 To evade the effects of antimicrobials, bacteria have developed multiple strategies 
to neutralize their effects including avoidance, target modification and protection, 
inactivation, and active elimination of the offending molecules from the bacterial 
cytoplasm. 
Intrinsic resistance 
Bacteria which exhibit intrinsic or innate resistance would include those which lack 
or restrict access to targets for the antimicrobial in question. For example, anaerobic 
bacteria are insensitive to aminoglycosides because of they’re inability to successfully 
carry out oxygen dependent antimicrobial transport across the cytopolasmic membrane and 
into the bacterial cell  [44]. Additionally, certain resistance determinants are permanent 
fixtures in the bacterial genome such as described in species of Aeromonas with 
chromosomally located β-lactamases [45]. 
Enzymatic degradation/inactivation 
Modification or destruction of antimicrobials to render them inactive is a strategy 
used by many bacteria for several classes of antimicrobial drugs including the 
aminoglycosides, macrolides, β-lactams and phenicols. Acetyltransferases for example are 
inactivating enzymes which are common to aminoglyocosides and phenicol resistance. 
Transfer of an acetyl group from an acetyl co-enzyme A donor to the antibiotic affects 
amino acid interaction and inhibits binding at strategic sites in the ribosome [46, 47]. 
Another example is the three constitutive chromosomal β-lactamases groups which can be 
present in some Aeromonas species including a penicillinase/carbapenemase, a 
cephalosporinase and an oxacillinase [45, 48]. They have different substrate preferences, 
7 
 
but their mode of action is similar, where enzymatic hydrolysis of amide bond in the β-
lactam ring is responsible for inactivation [49]. 
Reduced accumulation (efflux pumps) 
Antimicrobial avoidance by decreasing cytoplasmic concentrations of offending 
chemicals is common among many bacterial species. Bacterial efflux pumps serve as 
efficient gate keepers allowing entry of ions and nutrients, permitting communication 
between bacteria and their environment and limiting accumulation of unwanted 
metabolites or other toxic products [50]. In fact, it is quite likely that the affected 
antimicrobials are not the intended pump substrate. The first antimicrobial resistance efflux 
pumps were discovered on plasmids coding for resistance to tetracycline in E. coli, and 
have now been identified in many bacterial genera [51, 52]. Some efflux pumps may be 
substrate specific as is seen in bacteria which are producers of antimicrobial compounds 
such as the actinomycetes [53]. They may equally act upon many different substrates such 
as the multidrug resistance pump (MDR) AheABC of A. hydrophila described by Henrould 
(2008), and more than one efflux pump may be present in the same bacterium [54, 55]. 
Five major efflux pump classes have been identified including ATP binding cassettes 
(ABC), resistance nodulation cell division (RND), major faciliator superfamily (MFS), 
small multidrug resistance (SMR) and multidrug and toxic compound extrusion (MATE) 
[50, 56]. The ABC efflux pumps use ATP as the energy source to drive antimicrobial 
export, whereas MFS, SMR and RND efflux systems use the proton motive force (PMF) of 
the transmembrane electrochemical proton gradient to effectuate this action. MATE export 
pumps in contrast are considered H+ or Na+ coupled drug transporters [57]. Although 
differing in action, it remains that all functionally are considered to be capable of 
transporting a wide variety of substances including antimicrobials [56]. MFS, RND and 
SMR efflux pumps have been identified in Aeromonas species, whereas RND, MFS, SMR 
and MATE classes have been described in Vibrio sp. [50, 58]. 
Target modification and protection 
Bacteria can evade antimicrobial action by modifiying or shielding antimicrobial 
targets to render them refractory to antimicrobial effects. This can arise from a mutational 
event or from horizontal gene transfer. Perhaps one of the best characterized is the 
resistance to sulfonamides via their interaction with folic acid metatoblism. Folic acid is an 
8 
 
important intermediate in many vital metabolic pathways in bacteria including the 
production of DNA and NADPH among others. Sulfonamides act as structural analogs of 
p-amino benzoic acid which competes for the dihydropteroic acid synthase enzyme 
(DHPS), thereby inhibiting the production of folic acid [59]. The acquisition of genes 
coding for DHPS enzymes with greater affinity for p-amino benzoic acid than 
sulfonamides renders the bacteria resistant [59]. This type of resistance has been reported 
in both Aeromonas and Vibrio genera. 
Resistance acquisition 
Acquired resistance refers to a modification or acquisition of genetic material 
which confers antimicrobial resistance to a bacterium. This may be associated with 
mutation of the bacterial genome conferring resistance or transfer and incorporation of 
resistance determinants via exchange of naked DNA, bacteriophage infection or mobile 
genetic structures such as plasmids, transposons and integrative conjugative elements 
(ICE’s) [60]. Collectively, these non-mutational mechanisms are referred to as horizontal 
gene transfer or HGT. Further, the maintenance of acquired genes is generally facilitated 
by environmental selective pressure where survival of the bacteria with the genetic 
modifications is favoured, as with chronic antibacterial use in hospitals or animal 
production for example. 
Mutation 
Spontaneous mutation of the bacterial genome occurs during normal bacterial 
growth due to copy errors in DNA replication. Mutation rates are variable, dependent upon 
the bacteria under consideration but are generally found to be 10
-10
 – 10
-9
 per base pair 
replicated [61]. Those bacteria harbouring a mutation which is beneficial to survival in a 
given environment are favoured. Therefore in a situation where a bacterium is exposed to 
an “antimicrobial environment”, those with an adaptive resistant mutation will survive, 
followed by clonal expansion of the bacterium within the bacterial population. Resistance 
to quinolones (ex. naladixic acid) is an example where point mutations principally in the 
gyrase (gyrA) or topoisomerase IV (parC) genes confer increased resistance to 1
st
 and 2
nd
 
generation quinolones [48, 62] 
Transformation 
Transformation refers to the bacterial uptake of naked DNA from the environment 
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resulting in a different genotype [63]. Experimental or in-vitro transformation is used to 
artificially introduce DNA into bacteria following competence induction by chemical, 
physical or enzymatic treatments. Natural transformation is a function encoded in the 
bacterial genome and implies the survival of naked DNA in the environment, localisation 
and internalisation by a competent host followed by incorporation into the host genome. 
This type of acquisition occurs in both Gram-positive and Gram-negative species although 
they differ principally because of the differences in cellular barriers [64]. Natural 
transformation of plasmid DNA has been reported for Vibrio sp. with frequencies ranging 
from 0.3 to 3.1 x 10
-8
 transformants/recipient in sediment microcosms [65]. AMR transfer 
by transformation has not been described in Vibrio or Aeromonas, but is a well known 
mechanism first recognized in the Gram-positive species Streptococcus pneumonia [66, 
67]. More recently, Neilsen (2010), describes transfer of  erm (B), mef (E), mef (I), tet (M) 
and catQ genes between streptococcal isolates [68]. Although it has been argued that this 
form of genetic exchange is less important than conjugative events as they relate to HGT 
and AMR, transformation does not require conjugative elements, physical contact, or even 
a live DNA donor [69]. Therefore, its importance in complex bacterial communities such 
as biofilms may be underestimated. 
Transduction 
Bacterial infection with viral particles or bacteriophages may also occasion the 
transfer of genetic material between bacteria resulting in the incorporation of novel genetic 
material into the bacterial genome [70]. Bacteriophages are ubiquitous microorganisms 
endowed with a simple structure including the viral coat or capsid, an injection apparatus 
and the genetic material, variably DNA or RNA being simple or double stranded [71]. The 
viral infection of bacteria may have two general results: bacterial death (lytic phages) or 
incorporation of viral DNA into the bacterial genome (lysogenic phages). Cellular targets 
of bacteriophages are not clearly understood, however it is generally considered that they 
are specific to receptor types and likely to bacterial species and are not a probable genetic 
transfer mechanism between distantly related bacterial genera. However, it has been shown 
recently that transfer of virulence determinants between different bacterial genera via 
bacteriophages can occur with as high a frequency as intrageneric exchange [72]. 
Bacteriophage DNA capacity may effectively limit the efficacity of resistant determinant 
transfer. Bacteriophages are known to be important for the transmission of virulence 
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factors such as the case with the CTX prophage coding for cholera toxin in Vibrio 
cholerae. Lan (2009) describes prophages in Vibrio parahemolyticus containing putative 
bacterial DNA. They suggest that this bacteriophage may be involved in horizontal genetic 
exchange and may contribute to bacterial genetic diversity in this species [70]. Large 
bacteriophage capacity is estimated to be approximately 200 kb wherein resistance 
determinants such as tet(A) (1250 bp) and cat (1348 bp) would fit comfortably [71, 73-75].  
Additionally, bacteriophages in the aquatic environment are considered the most abundant 
biological entity (up tot 2.5x10
8
 per ml) and presumably an important element for genetic 
diversification [76, 77]. Bacteriophages have been shown to transfer various AMR 
determinants in Pseudomonas aeruginosa [78] . Although there are numerous references to 
bacteriophages reported in the literature concerning Aeromonas and Vibrio species, there is 
no specific mention of AMR containing viral particles [79, 80]. 
Conjugation 
Conjugation refers to the exhange of DNA between bacteria via pili, and is often 
erroneously referred to as “sexual reproduction”. Requirements for successful conjugation 
include the intimate (direct) contact of a gene donor and recipient, the gene targeted for 
transfer and the presence of the “machinery” necessary for the transfer of the genetic 
material. The most commonly recognized conjugative mechanism is plasmid mediated 
genetic exchange, first described in E. coli by Tatum and Lederberg in 1947 [81]. Plasmids 
are autonomously replicating, extrachromosomal circular or linear double stranded DNA 
fragments, with sizes ranging form 300 bp to 2400 kpb [82]. Minimally, a conjugative 
plasmid must contain transfer genes (tra), which code for the pilus assembly and 
associated transfer related proteins as well as a replicative starting point or origin of 
transfer (oriT) which is distinct from oriR which is necessary for intrabacterial replication 
[83]. This is followed by a transfer of one DNA strand to the recipient cell and the 
synthesis of the complementary strands in the donor and recipient cells. The transmission 
of resistance determinants associated with plasmids has been reported by many authors and 
transfer frequency in experiments between A. salmonicida and E. coli in the laboratory 
have been found to range between 10
-1
 – 10
-9
 [7, 39, 84, 85]. Upon examining plasmid 
transfer in a natural microenvironment involving salmon contaminated with resistant A. 
salmonicida and E. coli on a cutting board, a transfer frequency of 3 x 10
-6
 to 8 x 10
-3
 was 
noted [6]. Broad host range plasmids such as the IncU class possess shorter rigid pili which 
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lend to greater transfer efficiency, as much as 2,000 to 300,000 times faster on solid 
surfaces [43, 86, 87]. This is an important distinction when considering consumer risk 
originating from aquatic animals or their environment. Coexistence of different plasmids 
within the same bacterium is possible, however, two plasmids which share the same or 
similar types of plasmid transfer genes (considered as being of the same incompatibility 
group) are inhibitory to each other [83]. Certain types of plasmid incompatibility groups 
may be more commonly associated with specific bacterial genera. The plasmids of the 
incompatibility groups U and C are the most common in the aermonads, whereas group C 
plasmids are found principally in Vibrio species [88-90]. Plasmids from these 
incompatibility groups have a wide host range and have been associated with phenotypic 
resistance in these species. 
Not all plasmids are capable of conjugative transfer. Smaller plasmids which do not 
contain the necessary 35 kb of transfer genes may piggyback on other mobile plasmids if 
they simply contain the appropriate origin of replication (oriT) recognized by the transfer 
machinery of the co-residing plasmid. Most early studies examining the genetic causes of 
antimicrobial resistance phenotypes concentrated on the absence or presence of mobile 
genetic elements which could confer AMR to sensitive bacterial strains. Aeromonas and 
Vibrio species are known to harbour a plethora of plasmids, ranging in size from 11 – 200 
kbp, coding for  resistance to various antibiotics [8].  
Transposition 
DNA elements which can “hop” or transpose from one location to another in 
bacteria are called transposons. They consist minimally of an open reading frame coding 
for a transposase enzyme (which controls their movement among different DNA locations) 
bounded by inverted repeats. These most simple transposons are called insertion sequence 
elements (IS) and may be only 1000 bp in length. IS’s may “hop” close enough together on 
chromosomes or plasmids to mobilize the intervening DNA forming “composite 
transposons” [83]. This interaction of related transposons may mobilize larger DNA 
elements, including AMR genes, within the bacterium. Non-composite transposons may 
also contain AMR genes as a part of the minimal transposable unit . They may also have 
the capacity to integrate AMR genes or “cassettes” due to the presence of integrons in their 
structure (see below). Transposons in association with plasmids and integrons appear to be 
involved in long-range AMR distribution. The truncated or complete transposon Tn1721 
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containing tet(A) for example, has been found on pRAS1 or pRAS1-like plasmids in A. 
salmonicida from different regions including Scotland, Norway and  Japan [4, 43, 91]. 
Integrative elements 
Integrons are genetic elements capable of capturing and incorporating genetic 
material into their DNA structure. They are not capable of self replication or transmission, 
but are rendered “mobile” by other mobile genetic platforms such as transposons and 
plasmids. The integrons have been categorized into classes depending on the type of 
integrase that is incorporated in their structure (intI1, intI2, intI3 and intI4). Classes 1-4 
have been identified in Aeromonas and Vibrio sp. Class 1 integrons contain minimally a 
gene coding for an integrase enzyme (intI), a promoter and a recombination site (attI) in 
the 5’ conserved segment of the integron [92]. The components intI and attI act on gene 
cassettes which are comprised of a promoterless gene, often coding for antimicrobial 
resistance, and a recombination site (attC) recognizing the complementary site (attI) of the 
integron [93]. Integrated genes become a part of the integron structure and many genes 
cassettes may become associated with the integron. PCR amplification of the variable 
region of the integron permits the identification of the residing cassettes. Class 1 integrons, 
thought to be degenerate transposons, are the most common in Gram-negative bacteria. 
They usually contain sul1 and qacE∆ genes, coding for resistance to sulfonamides and 
quaternary ammonium compounds respectively, and an open reading frame (orf) of 
unknown function in their conserved 3’ segment, downstream of the attcI site. The 
presence of sul1, along with qacE∆ is often used as markers for class 1 integrons though 
the presence of these genes or truncated relatives is variable [94, 95]. The functional 
capacity of the integron to accumulate resistance gene cassettes as well as the inclusion of 
resistant genes in their basic structure (ex. sul1 in class 1 integrons) can lead to variable 
AMR phenotypes often exhibiting multiple drug resistance (MDR) in addition to 
diaminopyramidine resistance. Class 2 integrons have a similar structure and are found 
within transposons of the Tn7 family, commonly code for trimethoprim resistance (dhf) 
[96, 97]. Class 2 integrons appear to be more limited in resistance cassette arrangements 
than Class 1, likely due to a non-functional integrase gene [96]. The recently described 
Class 3 integrons have a similar organization to Class 1 and Class 2 integrons including the 
capacity to carry resistance determinants [98]. Their presence was signalled in Aeromonas 
sp. from the african aquaculture environment [95]. Finally, Class 4 integrons have been 
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identified on the small chromosome of Vibrio cholerae, containing 100’s of genes of 
mostly unknown function [99, 100]. Although the origin of integrons is unclear, these 
“Super-integrons” identified in Vibrio and also in Pseudomonas species are thought to be 
involved in their presence [101, 102]. Tapping into this vast depot of genetic material in 
the super-integrons may partly explain the seeming ease with which bacteria adjust to new 
antimicrobial molecules [103]. The presence of integrons is commonly reported in aquatic 
bacteria and clinical Aeromonas and Vibrio isolates [95, 104-112]. Class 1 integron 
carriage has been reported as varying from 3.6 – 73% [94, 95, 106, 107, 113]. These 
studies indicate that not only are Aeromonas and Vibrio species present in diverse 
environments, both as disease causing agents and commensals, but also that the various 
integron types are equally present which may contribute to resistance determinant mobility. 
This supports the argument that antimicrobial pressure in the environment is important for 
the maintenance and spread of AMR determinants in the bacterial population.  
Integrating conjugative elements (ICE’s) or Genomic islands (GIs) 
In the early 1980’s transposons were identified which not only had the capacity to 
integrate into the bacterial genome but also a conjugative capacity. ICE’s tend to be large 
DNA structures due to the accompanying tra genes necessary for conjugative transfer 
however they are incapable of autonomous replication like plasmids [114].   Their DNA 
excision and integration functions (xis and int genes) resemble more phages than true 
transposons, hence their name [115]. Recently, it has been argued they should be included 
in a larger overarching family of syntenic blocks of transferred DNA called Genomic 
islands or GI’s [83, 115]. The interbacterial transfer mechanism however, is similar to 
plasmids, where following excision from the bacterial DNA, a circular DNA intermediate 
where an oriT sequence is formed. (Hinerfield and Senghas in Snyder)[116]. ICEs can 
code for a variety of functions including virulence factors, antimicrobial  resistance, and 
various metabolic functions [115]. The first ICE’s, were identified in Streptococcus 
faecalis and Bacteroides fragilis in the early 1980’s and were followed by several others 
[117, 118]. In 1996 Waldor et al. identified the first ICE in the Vibrionaceae, named SXT, 
in Vibrio cholerae [119]. Beaber described the SXT sequence as a melting pot of 
composite genes including those from bacteriophages, plasmids and other diverse sources 
[120]. The SXT element or “constin” (conjugative, self-transmissible, and integrating) has 
been found to be capable of antimicrobial resistance mediation, often in association with 
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integrons and transposons, and may also play a role in mobilizing plasmids carrying 
resistance determinants [121-123]. The resistance genes floR, strA, strB, sul2, dfrA18, and 
dfrA1 have been associated with presence of V. cholerae SXT constin [124]. 
Antimicrobial resistance in Aeromonas and Vibrio 
β-lactams 
The β-lactam class of antibiotics includes the penicillins and the cephalosporins, 
carbapenems and monobactams, all characterized by a central β-lactam ring. This class of 
antibiotics are structural analogs of the terminal acyl-D-alanyl-D-alanine of the bacterial 
cell wall peptidoglycan subunit. Penicillin bindings proteins (PBP’s) preferentially bind the 
β-lactams leading to an inhibition of cell wall synthesis and cell death [125]. Resistance to 
β-lactams is derived from multiple mechanisms including antimicrobial efflux, mutation of 
PBP’s (reducing penicillin binding affinity), β-lactamase activity, overexpression of 
intrinsic β-lactamase activity and decreased permeability [49]. 
PBP’s and their mutant variants are normally associated with resistance to β-
lactams in Gram-positive bacteria and have not been reported to be a mechanism of 
importance for Aeromonas, Vibrio spp. or other Gram-negative bacteria associated with the 
presence of a plethora of β-lactamases in these species. Decreased outer membrane 
permeability in Gram-negative bacteria can be associated with low level resistance to the 
β-lactams as well as other antimicrobials. Oliver (2002) noted that alterations in porin 
expression in E. coli were linked to differences in β-lactam susceptibility, and furthermore 
Nikaido (1987) demonstrated a synergism between β-lactamase presence and decreased 
membrane permeability resulting in increased AMR in E. coli [126, 127]. Similar results 
have been shown for A. salmonicida where mutants with changes in outer membrane 
proteins demonstrated higher levels of AMR, including the β-lactams [128-130]. 
β-lactamase production by Gram-negative bacteria is the most important element 
when considering innate (chromosomal) and acquired resistance to β-lactams. Several 
classification schemes have been proposed for these enzymes based on molecular or 
functional characteristics, those of Ambler (1980) and Bush (1989, 1995) among the most 
commonly cited in the published literature [131-133]. The Ambler scheme proposes four 
classes (A-D) based on amino acid sequences where classes A, C and D are serine 
proteases and class B is a metallo-β-lactamase. The Bush scheme classifies β-lactamases as 
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to their preferred substrate and inhibiting molecules resulting in a more complex separation 
of enzymes [131, 133, 134]. These classifications schemes are contrasted in Annex 1.0, 
with mention of enzymes and substrates particular to each class. 
Several enzymes classified loosely as pencillinases have been identified in 
Aeromonas and Vibrio. Aeromonads are generally considered resistant to penicillins due to 
the commonly identified chromosomally located β-lactamase enzymes, CeP-S, AMP-S and 
CPH-S. Vibrio species are not known to possess similar chromosomal enzymes. The 
presence of chromosomal β-lactamases in Aeromonas can be quite variable, where a 
penicillinase, a cephalosporinase and/or  a metallo-β-lactamase may be present in different 
combinations depending on the species and strain examined [45, 135].  Walsh (1997) 
evaluated the prevalence of the three chromosomal β-lactamase genes in different 
Aeromonas species and found the blaAmp-S gene presence varied from 25 - 45% depending 
on the species, with A. veronii having the highest prevalence at 45% [136].  The blaCep-S 
gene was almost uniformly present in the A. caviae, A. veronii and A. hydrophila strains 
examined and its presence confers resistance to 1
st
 generation cephalosporins [133, 136]. 
Although the chromosomal β-lactamases are considered immobile, others have 
been identified on mobile genetic structures making them more important when 
considering HGT of resistance elements.  They are commonly found present as gene 
cassettes in class 1 integrons, with either a plasmidic or chromosomal location. In most 
cases they were associated with resistance determinants for other antimicrobials within the 
same integron or plasmid [106, 137]. 
The extended spectrum β-lactamases (ESBL’s) have become extremely important 
when considering β-lactam therapy due to their large spectrum of activity, and their genetic 
mobility. ESBL’s are generally recognized as being capable of hydrolyzing penicillins, 1
st
, 
2
nd
, and 3
rd
 generation cephalosporins (with the exception of cephamycins and 
carbapenems) and monobactams [138].  To date three ESBL’s have been identified in both 
the Aeromonas and Vibrio genera (see Table I below). 
The metallo-β-lactamases (MBL) to date have only been recognized in Aeromonas 
species. They are categorized as Bush class 3/Ambler class B and can hydrolyze most 
classes of β-lactams. [134]. Wild chromosomal MBL + strains may be differentiated form 
acquired MBL’s due to their susceptibility to carbapenem [139].  Acquired MBL’s are 
commonly found as gene cassettes within class1 integrons and as such may be associated 
with other AMR determinants. European MBL’s strains often exhibit a truncated gene 
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cassette fused with the gene aacA4, resulting in resistance cross-selection between 
aminoglycosides and β-lactam [139]. The following table denotes the various determinants 
responsible for β-lactam resistance described for Aeromonas and Vibrio sp. Additional 
information concerning the β-lactamase genes described above as well as available 
associated MIC data can be found in Annex 1 and 2.  
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Table I Aeromonas and Vibrio β-lactam resistance genes 
Gene Species/genus Bush-Ambler class
a
 
Associated genetic 
element 
Ref. 
Aeromonas/Penicillinases 
blaSHV A. media 2b-A - [140] 
blaTEM Aeromonas sp. 2b-A - [140] 
blaOXA-2 Aeromonas sp. 2d-D Class 1 integron 
[95, 106, 
140] 
blaOXA-21 Aeromonas sp. 2d-D Class 1 integron [107] 
blaPSE-1 
Aeromonas sp. 
 
2d-D Class 1 integron [95] 
Vibrio/Penicillinases 
blaSAR-1 V. cholerae 2b-A Plasmid [141] 
blaTEM-1 V. cholerae 2c-A Plasmid [142, 143] 
blaCARB2 V. cholerae 2c-A Class 1 integron 
[104, 112, 
144] 
blaCARB6,7,9 V. cholerae 2c-A Chromosome [145-147] 
Aeromonas/Extended spectrum β-lactamases, cephalosporinases 
blaCMY-2 A. salmonicida 1-C IncA/C plasmid [39] 
blaCep-S Aeromonas sp. 1-C Chromosome [136] 
blaTEM-24 
A. caviae, 
A. hydrophila 
2be-A Plasmid [135, 148] 
blaPER-1 V. cholerae 2be-A Plasmid [142] 
Vibrio/Extended spectrum β-lactamases, cephalosporinases 
blaCTX-M-2like V. cholerae 2be-A Plasmid [142] 
blaPER-2 V. cholerae 2be-A Plasmid [142] 
blaOXA-142 V. fluvialis 2be-A Class 1 integron [109] 
blaAmp-C V. fischeri 1-C Chromosome [149] 
Aeromonas/Metallo-β-lactamases 
blaCph-A Aeromonas sp. 3-B Chromosome [150, 151] 
blaIMP-19 A. caviae 3-B Class 1 integron [152] 
blaVIM-4 A. hydrophila 3-B Class 1 integron [153] 
a
 Additional information concerning β-lactamases is found in Annex 1 
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Tetracyclines  
Tetracyclines are bacteriostatic antimicrobial compounds derived from 
Streptomyces spp. Their effects are mediated by the interaction with the 30S subunit of the 
ribosome, thereby preventing association with aminoacyltRNA and thus protein synthesis 
[154]. Resistance to the tetracycline family was recognized in Aeromonas species as early 
as 1959 by Snieszko and later attributed to a transferable R factor by Aoki in 1971 [155]. 
At least 41 tetracycline resistance genes have been characterized to date. They are divided 
into four classes including efflux proteins (26), ribosomal protection proteins (11), 
enzymatic modifying proteins (3), and one with an unknown mechanism [156, 157].  
The first category, the efflux proteins, which are members of the major facilitator  
superfamily (MFS), reduce intrabacterial tetracycline concentrations via an energy 
dependent protonic exchange [158]. The efflux proteins associated with tetracycline 
resistance in Gram-negative bacteria are doted with two components, a repressor and an 
efflux protein, where in the presence of tetracycline, the efflux protein coding gene is 
derepressed allowing transcription [154]. The tet efflux genes are not found as gene 
cassettes within class 1 integrons, however they are commonly found in other mobile 
genetic structures such as on mobile plasmids and within transposons [73, 84, 157, 159]. 
The tet(A) gene is an  example of a tet gene which has been associated with full or 
truncated Tn1721 transposon in A. salmonicida and other Aeromonas species [43, 85]. 
Early studies localized certain tet efflux genes on nonmobile plasmids or chromosomes due 
to apparent low experimental transfer frequencies [160, 161]. Subsequently, other authors 
have described these genes as highly prevalent on transferable plasmids, perhaps due to 
different or improved experimental methods [161-164]. Due to the plasmidic location of tet 
genes co-resistance to other antimicrobials is often reported. Co-resistance to sulfonamides 
± trimethoprim as well as streptomycin is common, likely due to presence of integrons on 
tet determinant containing plasmids [7, 85, 95]. The tet efflux genes are commonly found 
singly, but they may also cohabit in the same bacteria either chromosomally or on the same 
mobile genetic element with other tet genes or resistance determinants to other antibiotic 
classes [154]. Determinant combinations in Aeromonas spp. have been reported in various 
studies, including tet(A)-tet(E), tet(B)-(D), tet(A)-tet(C), and tet(E)-tet(D) and even tet(A), 
tet(B), tet(D)/tet(H), and tet(E) [95, 159-161, 163, 164]. The presence of more than one tet 
determinant has also been signalled in Vibrio spp. including tet(A)/tet(B), 
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tet(A)/tet(B)/tet(D), tet(D)/tet(E) combinations [165, 166]. Therefore, one or combinations 
of tet determinants may be responsible for observed phenotypes in these genera.  
Seven efflux tet genes have been identified in Aeromonas species to date including 
tet(A), tet(B), tet(C), tet(D), tet(E), tet(Y), tet(31). The tet(A) and tet(E) determinants are 
often quoted as being the most common although few studies have examined the 
prevalence of all tet determinants within a bacterial population. There have also been 
differences ascribed to variations in molecular techniques such as multiplex and single 
PCR protocols [163].  Prevalence for tet(A) in tetracycline resistant strains varies between 
3 and 88% [4, 7, 84, 85, 91, 95, 160, 161, 163, 167], whereas prevalence of tet(E) genes 
among resistant isolates has been reported anywhere from 42% to 90% [95, 159-161, 163, 
168-170]. The tet genes B, C and D appear to be present in lower numbers, ranging from 
as little as 1% to 28% in resistant bacteria [169, 170]. The lack of identifiable tet 
determinants in the literature is common [5, 7, 160, 161, 170]. In a study by Schmidt 
(2001) for example, only 30% (66/216) resistant isolates could be assigned a known tet 
determinant [7]. 
Several efflux pumps have also been identified in Vibrio species including tet(A), 
tet(B), tet(C), tet(D), tet(E), tet(G), and tet(35). The determinants tet(D) and tet(B) seem to 
be identified with a greater frequency in marine environments. The prevalence of tet(B) in 
Vibrio was 43% and 100% in studies conducted by Furushita (2003) and  Kim (2007) 
respectively [5, 171]. The tet35 gene was identified in a tetracycline resistant strain of V. 
harveyi isolated from a prawn. Unlike previous tetracycline export pumps identified, tet35 
appears to have a primary physiological role in Na+/H+ transport rather than antimicrobial 
export, is chromosomally located and results in inferior MIC’s in transconjugants as 
compared to tet(A) for example [172].    
The second class of tet resistance genes are the ribosomal protection proteins 
(RPP’s). These act by permitting continual protein synthesis in the presence of 
tetracyclines. Although traditionally considered as Gram-positive tetracycline resistance 
genes these are now being identified in other cases including Gram-negative aquatic 
bacteria [171]. The determinant tet(M) is the only RPP identified among Vibrio and 
Aeromonas species [157]. It can be found in co-residence with other tet determinants such 
as tet(B), tet(D) and/or tet(E) [164, 165, 173]. The tet(M) determinant was the most 
common among tetracycline resistant Aeromonas isolates in an Australian study, where 7 
out of 10 (70%) harboured the gene [164]. In Korean Vibrio isolates, the tet(M) and tet(B) 
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duo were found in 23 of 24 isolates and both tet determinants were located within a Tn10 
tranposon. Similarly, Kim (2004) examined the tet resistance genes from 151 tetracycline 
resistant marine bacteria originating from Japan and Korea. The majority of the tet(M) 
positive Vibrio isolates were found to be associated with a transposon of the Tn1545-
Tn1916 family and interestingly the Gram-positive bacteria, Lactococcus gerviae 
examined in the same study, carried a similar gene/transposon combination. The 
association of tet(M) resistance elements with transposable elements may be responsible 
for this ever-enlarging host range [154].  
The last class of tet resistance elements are the enzymatic proteins which inhibit 
tetracycline activity by inactivation of the antimicrobial or by an acceleration of protein 
transcription bypassing the tet resistance mechanism and includes tet(34), tet(X) and 
tet(37) (refer to Annex 5) [174, 175].  They act via an NADPH-requiring oxidoreductase 
(tet(37) and tet(X)), or an enzyme similar to xanthine–guanine phosphoribosyl transferase 
from Vibrio cholerae (tet(34)).  The tet(34) gene was identified in a Vibrio isolate grown 
from marine fish intestinal contents, and was associated with the relatively high MIC of 
500μg/ml to oxytetracycline [174]. Additional information concerning the tetracycline 
resistance genes described above as well as available associated MIC data can be found in 
Tables II and III below and in Annex 3 and 4.  
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Table II Tetracycline resistance genes identified in Aeromonas sp. 
Genus/species Associated genetic elements Genes identifieda Ref. 
A. salmonicida 
pRAS1/pAr-32, Class 1 
integron, transposon 
dfrA16, qac, sul1 
tet(A),aadA2,qac,sul1, catAII 
[43] 
A. salmonicida pRAS2, Tn5393 tet(31), sulII, strA, strB [176] 
A. salmonicida pRAS3 tet(C) [177] 
A.salmonicida, 
atypical 
pRAS-1 like, Tn1721, IS6100 dfrA16, sul1, tet(A), tet(B) [85] 
A. salmonicida pASOT tet(A) [84] 
Aeromonas sp. pFBAOT, Tn1721 tet(A) [4] 
A. caviae(punctata) 
pFBAOT6,Class 1 integron, 
transposon 
tet(A), sul1,qacEd1, aadA2 [178] 
Aeromonas sp. pSS2, chromosome tet(A), tet(E) [160] 
A .hydrophila - tet(A),tet(E) [161] 
Aeromonas sp. - tet(A), tet(B), tet(C), tet(D), tet(E) [167] 
A. bestiarum pAB5S9, ICE floR, tet(Y), strA, strB, sul2 [179] 
Aeromonas spp. Class 1 integron, plasmid  
ant(3”)Ia, aac(6’)Ia, dhfr1, 
blaOXA2a, blaPSE1 
tet(A),tet(B),tet(D),tet(E), 
tet(H) 
[95] 
A.hydrophila and 
A.salmonicida 
R-plasmid tet(E), tet(A), tet(D) [163] 
A. hydrophila 
pJA5017, pES15, pES41, 
pTW537 
tet(D) [180] 
A. veronii Plasmid tet(A)-tet(E) [169] 
A. salmonicida Class 1 integron, plasmid  
ant(3”)1a, dhfr1, dhfrIIc, dhfrXVI, 
tet(A), tet(C), sul1 
[159] 
A. salmonicida 
Class 1 integron, plasmid 
(pSN254-like) 
aadA7, florR, tet(A), sul2, strA, 
strB, sul1, blaCMY-2, sugE, Hg 
[39] 
Aeromonas sp. Plasmid/chromosome? tet(A), tet(E), tet(M), tet(D) [164] 
Aeromonas sp. Class 1 integron, plasmid  
tet(A),tet(E),tet(D), dhfr1, 
dhfr2a,ant(3”)1a, catB2 
[7] 
A .salmonicida Class 1 integron, plasmid  
tet(A), tet(E), sul2,aadA1,aadA2, 
dfr16, dfrfIIc, [91] 
A. hydrophila - tet(E), tet(D) [170] 
a
Tetracycline resistance genes are highlighted in bold faced type 
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Table III Tetracycline resistance genes identified in Vibrio sp. 
Genus/species Genetic element Genes identified
a
 Ref. 
Vibrio spp. - 
florR, catII, catIV, tet(B), 
tet(D), tet(E), tet(M) 
[181] 
Vibrio spp. - 
tet(A), tet(B), tet(D), catII, 
catIV 
[166] 
Vibrio spp. - 
tet(A), tet(B), tet(D), tet(M), 
catII, floR, 
[165] 
Vibrio spp. - tet(A), tet(B),tet(G) [182] 
Vibrio spp. - 
catIV, catII, tet(A), tet(D), 
tet(B) 
[183] 
Vibrio spp. 
Transposon Tn1545-
Tn916 family 
tet(M) [171] 
Vibrio sp. 
Chromosomal (or 
low copy plasmid) 
tet(34) [174] 
V. anguillarum Plasmid tet(E) [184] 
V. salmonicida pRVS1 tet(E) [162] 
V. harveyi 
Chromosome 
(tet35), 
plasmid?(tetA), Tn10 
tet(A), tet(35) [172] 
V. fluvialis  tet(E) [167] 
Vibrio sp. Tn10, plasmid? tet(M), tet(B) [173] 
V. anguillum pJA4320, pJA7601 tet(G) 
[74, 
184] 
Vibrio sp. 
Plasmid, 
chromosome? 
tet(A), tet(E), tet(M) [164] 
Vibrio/Photobacterium 
Plasmid? 
(conjugaison) 
tet(B), tet(Y) [5] 
V. cholerae 
Class 1 integron, 
plasmid, SXT 
aadA2, sul1, tet(A) [185] 
V. cholerae, V. 
parahaemolyticus 
Class 1 integron, 
plasmid 
dfrA15 , blaP1, qacH,  aadA8, 
tet(G), aph, cat1, sul2 
[104] 
V. cholera 
Class 1 integron, 
SXT 
aadA1, floR, strA, strB, sul2, 
tet(A) 
[124] 
a
Tetracycline resistance genes are highlighted in bold faced type 
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Phenicols 
Phenicols are bacteriostatic compounds which were originally derived from 
Streptomycetes. These compounds inhibit protein production via reversible binding with 
the 50S subunit of the ribosome of prokaryotes. Resistance to the phenicols has been 
attributed principally to enyzmatic modification of the antimicrobial and efflux proteins. 
The most common mechanism of enzymatic modification is via acetylation by a 
choramphenicol acetyltransferase (CATs), 24–26 kDa homotrimer proteins, which 
effectively inactivates the drug via deprotonation and transfer of an acetyl group from 
acetyl-CoA to the C3 alcohol of the choramphenciol molecule [186]. Schwarz (2004) 
classified cat genes into types A and B, the former being the classical CAT genes and the 
latter being xenobiotic CATs, also referred to as XATs [186, 187]. Within these CAT 
types, genes are further grouped according to an 80% similarity sequence identity ex. 
CAT1, 2 etc., and there are presently at least 16 type A groups and 5 of type B. The type A 
catI and catII genes appear to be the most common variants in Gram-negative bacteria 
coding for high level resistance to choramphenicol. Conversely, most Type B variants, 
associated primarily with Gram-negative bacteria impart low level resistance even with 
sur-expression, which may indicate that the intended acetylation substrate may be 
something other than chloramphenicols [186, 187]. The substitution of the C3 alcohol of 
the chloramphenicol (CM) molecule by a fluor group, as is found in florfenicol (FFC), an 
antimicrobial commonly used in aquaculture, renders the antimicrobial resistant to the 
CAT enzymes [187].  The cat genes have been described as chromosomal elements, but 
are often associated with mobile genetic structures such as plasmids, transposons and 
integrons [187]. The genes cat1 and catB2 for example were first described in E.coli as 
being part of the transposons Tn9 and Tn2424 respectively [188-190]. More than one cat 
gene may be present in chloramphenicol resistant bacteria [186]. The second of the main 
mechanisms for chloramphenicol resistance are export proteins including specific and 
multidrug exporters. There are eight described classes with only classes 3 and 4 having 
activity against both chloramphenciol and florfenicol [187]. 
The florfenicol resistance gene, floR, first described in florfenicol resistant strains 
of Photobacterium damselae subsp. damselae in 1996, is the only representative of the 
CM/FFC export proteins found in Aeromonas and Vibrio species, and confers resistance to 
both chloramphenicol and florfenicol [179]. This gene has been associated with the SXT 
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constins (conjugative, self-transmissible, and integrating) which are chromosomal 
conjugative elements located downstream of the prfC (protein release factor) in Vibrio 
cholerae [120, 121]. In Vibrio it has been associated with resistance gene clusters within 
the SXT element [121, 124]. Partial sequences of the SXT element had also been found 
associated with floR in A. bestiarum, perhaps belying the role played by SXT in 
interspecies transmission of genetic material [179]. Tables IV and V summarise the 
identified phenicol resistance genes identified during this review. 
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Table IV Phenicol resistance genes identified in Aeromonas sp. 
Genus/species 
Associated genetic 
elements 
Genes identified
a Ref. 
A. salmonicida 
pRAS1/pAr-32, Class 1 
integron, transposon 
dfrA16, qac, sul1 tet(A), aadA2, 
qac, sul2, catAII 
[43] 
A. bestiarum pAB5S9, ICE, transposon floR, tet(Y), strA, strB,sul2 [179] 
Aeromonas spp. Class 1 integron 
dfr12, dfr2d,  aadA1, aadA2, 
blaoxa-2, catB3, catB8,qacE2 
[106] 
Aeromonas sp. 
Class 1 integron, 
chromosome 
blaOXA-2,blaTEM,bla SHV,cphA, 
dfrA12, aadA1, aadA2, catB8 
[140] 
Aeromonas spp. Class 1 integron 
aadA1, aadA2,aac-a4,aac(6’)-II, 
aac(6’)Ib,arr-2, arr-3, dfrA1, 
dfrA12, dfrA5, dfra17,dfra2d,d 
frV, blaoxa21,catB3, catB8, 
cmlA1,ereA2 
[107] 
A. 
allosaccharophila 
p34, integron 
qnrS2,aac(6’)-Ib-cr, blaoxa-
1,catB3, arr-3 
[137] 
A. salmonicida 
Plasmid (pSN254-like), 
Class 1 integron 
aadA7, florR, tet(A), sulII, 
strA/strB, sul1, blacmy-2, sugE, Hg 
[39] 
Aeromonas sp. Class 1 integron, plasmid 
tetA,tetE,tetD, dfr1, 
dhfr2a,ant(3”)1a, catB2 
[7] 
A. hydrophila - catII [191] 
Aeromonas sp. Class 1 integron 
dfr1, ant(3′′)1a, catB2, tet(A), 
tet(E) 
[7] 
a
Phenicol resistance genes are highlighted in bold faced type 
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Table V Phenicol resistance genes identified in Vibrio sp. 
Genus/species 
Associated genetic 
elements 
Genes identified
a Ref. 
Vibrio spp. - 
florR, catII, catIV, tet(B), 
tet(D), tet(E), tet(M) 
[181] 
Vibrio spp. - 
tet(A), tet(B), tet(D), catII, 
catIV 
[166] 
Vibrio spp. - 
tet(A), tet(B), tet(D), tet(M), 
catII, floR, 
[165] 
Vibrio spp. - 
catIV, catII, tet(A), tet(D), 
tet(B),  
[183] 
Vibrio-like 
bacteria 
Class 1 Integron 
dfrIIc, dfrXII,aadA1a, blaoxa2, 
catB3, catB5 
[94] 
Vibrio sp. - catIV [191] 
V. anguillarum Plasmid (Rms418) Cat [192] 
V. cholerae 
Transposon-like 
structure, SXT 
dfr18, floR,sul2, strA/strB [121] 
V. cholerae, V. 
parahaemolyticus 
Class 1 integron, 
plasmid 
dfrA15 , blaP1, qacH,  aadA8, 
tet(G), aph, cat1, sul2 
[104] 
V. cholerae Class 1 integron, SXT 
aadA1, floR, strA, strB, sul2, 
tet(A) 
[124] 
V. cholerae 
Chromosome 
(superintegron) 
catB9, dfr2B [193] 
a
Phenicol resistance genes are highlighted in bold faced type 
Sulfonamides and diaminopyrimidines 
The sulfonamides are the oldest family of antimicrobial compounds dating back to 
the early nineteen hundreds with the development of protonsil , the first commercially 
available antimicrobial, by Gerhard Domagk, whereas the diaminopyrimidines are among 
the most recently developed compounds becoming available in the 1960’s [194]. As 
previously described, sulfonamides and  diaminopyrimidines are structural analogs of p-
amino benzoic acid and folic acid respectively which compete for essential enzymes vital 
for cell function where they exert a bacteriostatic action on sensitive bacteria  [59]. 
Resistance to these compounds is principally associated with modification of the 
target enzymes dihydropteroic acid synthase (DHPS) and dihydrofolate reductase (DHFR), 
and to a lesser extent on the reduction of antimicrobial entry into the bacteria due to 
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multidrug efflux pumps. The modification of DHPS and DHFR enzymes can arise from 
mutations which render bacteria non-susceptible, however acquisition of resistant enzymes 
carried by mobile genetic elements is much more common. There are currently over 30 dfr 
genes identified in a variety of different bacterial species.  Some confusion exists in the 
literature pertaining to gene nomenclature and several names have been used for the same 
genes over the years.  For example, the gene dfrA1 has also been known as dfr, dhfr1 and 
the the type I  DHFR gene depending on the publication consulted.  Current accepted 
nomenclature has divided genes into two groups dfrA and dfrB, followed by an Arabic 
number designating the gene variant [195-197]. They are often encountered as gene 
cassettes within integrons, although they may be found independently on plasmids [196]. 
These integrons have in turn been associated with transposons such as Tn7 and Tn21 
where integration into chromosomal or plasmidic structures is important for AMR 
dissemination [198, 199].   A trimethoprim/sulfonamide resistance phenotype may be 
considered as an initial marker for their presence [7]. 
Only three mobile variants of the sulfonamide resistance genes have been described 
to date including sul1, sul2 and sul3 [59, 200, 201]. These genes are generally plasmid 
associated and sul1 has been associated with the Tn21 transposon family [200, 202]. The 
gene sul1is frequently found in the 3’ conserved end of the class 1 integron along with orf5 
and ∆qacE and is commonly found associated with other resistance cassettes although 
truncated forms or its absence is possible [94]. It is thought to originate from a transposon 
with a subsequent loss of mobility, as it resembles portions of Tn1721 and Tn1696 [43].  
The sul2 gene is less commonly encountered in Aeromonas than in Vibrio where it 
has been associated with the SXT constin in V. cholerae. In two studies, one examining a 
multiresistant plasmid identified in A. bestiarum, and the other in A. salmonicida, sul2 was 
identified in a DNA segment identical to, or with similarities to, the SXT fragment of V. 
cholerae belying its possible genetic origin [39, 179]. 
The SXT constin in V.cholerae can mediate resistance via the presence of a 
transposed antimicrobial resistance gene cluster commonly including floR, sul2, strA/strB 
coding for chloramphenicol, sulfonamide and streptomycin resistance respectively [121]. 
In recently described Vibrio cholerae isolates, the dfr genes dfrA1 (ElTor) and dfrA18 
(0139) have been identified conferring resistance to trimethoprim [121]. Conversely in 
Iwanaga’s (2004) study no dfr genes were found. The insertion and removal of transposons 
and integrons containing the dfrA18 and dfrA1 genes and further recombination within the 
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constin is probably responsible for this variability. 
The prevalence of dfr genes among Aeromonas sp. has been reported to vary from 
25 to 52% [91, 106, 107, 140, 159]. Certain authors attribute the elevated prevalence of 
these genes in the fish farming environment to the use of potentiated sulfonamides in 
treating fish diseases. Among human clinical isolates of V. cholerae, dfr gene prevalence 
varying from 13 - 32% [105, 144]. In a retrospective study of V. cholerae O1 epidemic 
isolates from Guinea-Bissau, all 6, 1997 isolates carried dhfr18 on class 1 integrons 
whereas this gene was absent from those of previous years. Table VI and VII list the 
various dfr and sul genes responsible for sulfonamide/potentiated sulfonamide resistance 
described for Aeromonas and Vibrio sp. in the literature. 
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Table VI Sulfonamide resistance genes identified in Aeromonas sp.  
Genus/species Associated genetic elements Genes identifieda Ref. 
A. salmonicida 
pRAS1/pAr-32, Class 1 
integron, transposon  
dfrA16, qac, sul1,  
tet(A), aadA2,qac, 
catAII 
[43] 
A. salmonicida pRAS2, transposon tet(31), sul2, strA,strB [176] 
A. salmonicida, atypical pRAS-1 like, Tn1721, IS6100 
dfra16, sul1, tet(A), 
tet(B) 
[85] 
A. caviae(punctata) 
pFBAOT6, Class 1 integron, 
transposon 
tet(A), sul1, qacEd1, 
aadA2 
[178] 
A. bestiarum pAB5S9, ICE, transposon 
floR, tet(Y), strA, strB, 
sul2 
[179] 
Aeromonas spp. Class 1 integron, plasmid  
ant(3”)Ia, aac(6’)Ia, 
dhfr1, blaoxa2a, pse1 
tet(A), tet(B), tet(D), 
tet(E), tet(H) 
[95] 
Aeromonas spp. Class 1 integron 
dfr12, dfr2d,  aadA1, 
aadA2, blaoxa-2, catB3, 
catB8, qacE2 
[106] 
A. salmonicida Class 1 integron, plasmid  
ant(3”)1a, dhfr1, 
dhfrIIc, dhfrXVI, 
tet(A), tet(C), sul1 
[159] 
Aeromonas sp. 
Class 1 integron, plasmid, 
chromosome 
blaOXA-2, blaTEM, blaSHV, 
cphA, dfrA12, aadA1, 
aadA2, catB8 
[140] 
Aeromonas spp. Class 1 integron,plasmid 
aadA1, aadA2, aac a4, 
aac(6’)-II, aac(6’)Ib, 
arr-2, arr-3, dfrA1, 
dfrA12, dfrA5, dfra17, 
dfra2d, dfrV, blaoxa21, 
catB3, catB8, cmlA1, 
ereA2 
[107] 
A. salmonicida 
Plasmid (pSN254-like), Class 1 
integron 
aadA7, florR, tet(A), 
sul2, strA, strB, sul1, 
blacmy-2, sugE, Hg 
[39] 
Aeromonas sp. Class 1 integron, plasmid 
tet(A), tet(E), tet(D), 
dhfr1, dhfr2a, 
ant(3”)1a, catB2 
[7] 
A. salmonicida 
Class 1 integron, plasmid, 
Tn1721 
Tet(A), tet(E), 
sul2,aadA1,aadA2, 
drf16, drfIIc 
[91] 
a
Sulfonamide resistance genes are highlighted in bold faced type 
 
30 
 
Table VII Sulfonamide resistance genes identified in Vibrio sp.  
Genus/species Associated genetic elements Genes identified
a
 Ref. 
V. fluvialis pBD146, Class 1 integron, SXT dfrV, arr3, blaOXA-142, aadA1 [109] 
V. cholerae 
(non01,non0139) 
Class 1 integron, plasmid, 
chromosome 
aac(6‘)-Ib, dfrA1, aadA1, 
dfrA12, aadA2,  dfrA15, 
dfrA5, ereA2, sul1, qac, 
[203] 
Vibrio-like 
bacteria 
Class 1 Integron 
dfrIIc, dfrXII, aadA1a, 
blaoxa2, catB3, catB5 
[94] 
V. cholerae Class 1 integron, plasmid dfrA12, ant(3")-1a [144] 
V. cholerae Class 1 integron, plasmid 
dfrA15, dfrA1, ant(3")-1a 
(aadA2), blaP1(blaCARB-2), 
aadB 
[204] 
V. cholerae SXT, Transposon-like structure dfr18, floR,sul2, strA, strB [121] 
V. cholerae 01 Class 1 integron ant(3”)-1a,sul [111] 
Vibrio spp. Class 1 integron, SXT dfrA15,blaP1, aadA2 [112] 
V. cholerae Class 1 integron, plasmid, SXT aadA2, sul1, tet(A) [185] 
V. cholerae Class 1 integron, SXT aadA1, dfrA15 [105] 
V. cholerae Plasmid dfr [205] 
V. cholerae 
Class 1 integron, plasmid, 
chromosome 
dfrA1, aad2 [206] 
V. cholerae, V. 
parahaemolyticus 
Class 1 integron, plasmid 
dfrA15 , blaP1, qacH,  aadA8, 
tetG, aph, cat1, sul2 
[104] 
V. cholerae Class 1 integron, SXT 
aadA1, floR, strA, strB, sul2, 
tet(A) 
[124] 
V. cholerae Chromosome,(superintegron) catB9, dfr2B [193] 
a
Sulfonamide resistance genes are highlighted in bold faced type 
Aminoglycosides and aminocyclitols 
The aminoglycosides and aminocylitols are a mix of natural occurring and 
synthetically derived compounds which are polar organic bases consisting of aminated 
sugars joined to a dibasic cylcitol via glycosidic linkages [46]. Their antibacterial activity 
depends upon active oxidative transport across the bacterial envelope whereupon attaining 
the cytosol the antimicrobial can interact with the bacterial ribosome. The binding of the 
aminoglycosides to the 30S ribosomal subunit causes subsequent misreading of the mRNA 
and aberrant protein synthesis resulting in death of susceptible species. Multiple resistance 
mechanisms to the aminoglycosides have been identified, including decreased 
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uptake/increased efflux, modification of the 16S rRNA via mutation or methylation and 
most commonly, enzymatic inactivation. 
Decrease uptake of aminoglycosides as a result of diminished permeability and/or 
increased export have been identified in Pseudomonads and E. coli respectively, which can 
lead to low level or intermediate resistance [46, 207]. 
Mutations which alter the aminoglycoside binding site in the ribosome may 
effectively increase resistance to this class of compounds. Meier (1994) for example, 
describes how a single point mutation in the 16S rRNA confers streptomycin resistance to 
Mycobacterium tuberculosis [208]. Methylation within the ribosomal aminoacyl site (A-
site) of the 16S rRNA also interferes with aminoglycoside binding and has been 
recognized as one of the means of self protection utilised by bacteria which produce 
aminoglocysides such as the Streptomyces [209]. Acquired ribosomal methylases have a 
varied spectrum of activity and may confer resistance to some or all aminoglycosides 
containing the deoxystreptamine ring, including gentamicin, tobramycin, amikacin and 
paromomycin [209, 210]. They are however, as yet unreported in Aeromonas or Vibrio 
species [211]. 
Enzymatic inactivation of the aminoglycosides is achieved by modification of 
either the amino groups via the acetyl-CoA dependent activity of the N-acetyltransferases 
(AAC) or the ATP dependent activity of the O-nucleotidyltransferases (ANT) and O-
phosphotransferases (APH) enzymes on hydroxyl groups [46]. Although there are only 
three mechamisms of inactivation, at least 50 aminoglycoside modifying enzymes have 
been described, therefore, within each class there are multiple variants. Moreover, the use 
of two different nomenclature systems, and the publication different  names for the same 
aminoglycoside modifying enzyme, makes nomenclature confusing [212, 213]. Shaw 
provides an excellent review of the nomenculature and spectrum of activity of the various 
aminoglycoside inactivating enzymes [214]. 
These enzymes are commonly but not uniquely found, on mobile genetic elements, 
and are among the most commonly encountered in aquatic bacteria. Although the 
assumption that antimicrobial exposure is necessary to develop and maintain resistance in a 
bacterial population, members of the aminoglycoside family are not used in aquaculture . 
Aminoglycoside resistance gene cassettes appear to be more stable in integron structures 
which may help explain the facility of their transmission and occurrence and stability [7]. 
Numerous publications report the presence of aminoglycoside resistance genes in 
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Aeromonas and Vibrio species. Tables VIII and IX summarise those identified during this 
review. 
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Table VIII Aminoglycoside resistance genes identified in Aeromonas sp. 
Genus/species 
Associated genetic 
elements 
Genes identified
a Ref. 
A. salmonicida 
pRAS1/pAr-32, Class 
1 integron, transposon 
dfrA16, qac, sul1 tet(A)/aadA2, qac, 
sulI, catAII 
[43] 
A. salmonicida pRAS2, transposon tet(31), sul2, strA, strB [176] 
A. 
caviae(punctata) 
pFBAOT6, Class 1 
integron, transposon 
tet(A), sul1,qacEd1, aadA2 [178] 
A. bestiarum 
pAB5S9, ICE, 
transposon 
floR, tet(Y), strA, strB, sul2 [179] 
Aeromonas spp. 
Class 1 integron, 
plasmid 
ant(3”)Ia, aac(6’)Ia, dhfr1, 
blaoxa2a, pse1, tet(A), tet(B), tet(D), 
tet(E), tet(H) 
[95] 
Aeromonas spp. Class 1 integron 
dfr12, dfr2d,  aadA1, aadA2, blaoxa-
2, catB3, catB8,qacE2 
[106] 
A. salmonicida 
Class 1 
integron/plasmid 
ant(3”)1a, dhfr1, dhfrIIc, dhfrXVI, 
tet(A), tet(C), sul1 
[159] 
Aeromonas sp. 
Class 1 integron, 
chromosome 
blaOXA-2, blaTEM, blaSHV, cphA, 
dfrA12, aadA1, aadA2, catB8 
[140] 
Aeromonas spp. Class 1 integron 
aadA1, aadA2, aac a4, aac(6’)-II, 
aac(6’)Ib, arr-2, arr-3, dfrA1, 
dfrA12, dfrA5, dfra17,dfra2d, dfrV, 
blaoxa21, catB3, catB8, cmlA1, ereA2 
[107] 
A. media Plasmid blaPER-1, aphA6, strA [215] 
A. hydrophila Class 1integron  blavim-4, aacA4 [216] 
A. caviae pJDB2 blaimp-19, aacA4 [152] 
A. 
allosaccharophila 
p34 (IncU), integron 
qnrS2, aac(6’)-Ib-cr, blaoxa-1, catB3, 
arr-3 
[137] 
A. salmonicida 
Plasmid (pSN254-
like), Class 1 integron 
aadA7, florR, tet(A), sul2, strA/strB, 
sul1, blacmy-2, sugE, Hg 
[39] 
Aeromonas sp. 
Class 1 integron, 
plasmid 
tet(A), tet(E), tet(D), dhfr1, dhfr2a, 
ant(3”)1a, catB2 
[7] 
A. salmonicida 
Class 1 integron, 
plasmid, Tn1721 
tet(A), tet(E), sul2, aadA1, aadA2, 
drf16, drfIIc, 
[91] 
a
Aminoglycoside resistance genes are highlighted in bold faced type 
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Table IX Aminoglycoside resistance genes identified in Vibrio sp. 
a
Aminoglycoside resistance genes are highlighted in bold faced type 
Quinolones 
The quinolones are broad spectrum antimicrobials possessing a two ringed 
quinolone nucleus (4-oxo-1,8-naphthyridin-3-carboxylic acid), with a carboxylic acid side 
chain and oxygen at carbons 3 and 4 respectively being important for antibacterial activity 
[217]. These first generation molecules (oxalinic acid, nalidixic acid as examples) were 
later modified with the addition of a fluorine at carbon 6 and various substitutions at other 
ring sites to give us the modern fluoroquinolones. The quinolones owe their antibacterial 
activity to a non-covalent binding of the DNA gyrase and/or topoisomerase IV, stabilising 
breaks in the DNA, inhibiting replication [218]. 
Decreased permeability of Gram-negative bacteria to antimicrobials due to 
alterations in porins and/or the phospholipid bilayer may be a factor in resistance to 
Genus/Species 
Associated genetic 
elements 
Genes identified
a
 Ref. 
V. fluvialis pBD146, Class 1 
integron, SXT 
dfrV  arr3, blaOXA-142, aadA1 [109] 
V. cholerae 
(non01,non0139) 
Class 1 integron, 
plasmid, chromosome, 
aac(6_)-Ib, dfrA1, aadA1, dfrA12, 
aadA,  dfrA15, dfrA5, ereA2, sul1, 
qac, 
[203] 
Vibrio-like bacteria 
Class 1integron dfrIIc, dfrXII, aadA1a, blaOXAOXA2, 
catB3, catB5 
[94] 
V. cholera 
Class 1 integron, 
plasmid 
dfrA12, ant(3")-1a [144] 
V. cholera 
Class 1 integron, 
plasmid 
dfrA15, dfrA1, ant(3")-1a (aadA2), 
blaP1(blaCARB-2), aadB 
[204] 
V. cholera 
Transposon-like 
structure,  SXT 
dfr18,  floR, sul2, strA/strB [121] 
V. fluvialis 
Class1 integron 
aac(3)-Id, aadA7 
[110] 
 
Vibrio cholerae 01 Class 1 integron ant(3”)-1a, sul1, [111] 
Vibrio spp. Class 1 integron,  SXT dfrA15, blaP1, aadA2 [112] 
V. cholera 
Class 1 integron, SXT, 
plasmid 
aadA2, sul1, tet(A) [185] 
V. cholera Class 1 integron, SXT aadA1, dfrA15 [105] 
V. cholera 
Class 1 integron, 
plasmid , chromosome 
dfrA1, aad2 [206] 
V. cholerae, 
 V. 
parahaemolyticus 
Class 1 integron, 
plasmid 
dfrA15 , blaP1, qacH,  aadA8, 
tet(G), aph, cat1, sul2 
[104] 
V. cholera Class 1 integron, SXT aadA1, floR, strA/B, sul2, tet(A) [124] 
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antimicrobials [219]. A decrease in the expression of the porin OmpF and outer membrane 
proteins of E. coli for example, can decrease the susceptibility to quinolones as well as 
other antimicrobials [220]. This type of change had been noted for A. salmonicida mutants 
which displayed low-level resistance to multiple antibiotics, including the quinolones, due 
to changes in outer membrane protein profiles [129]. 
The earliest type of resistance identified against the quinolones was associated with 
single or multiple point mutations in the QRDR (quinolone resistant determining region) 
of the gyrase gene (gyrA/gyrB) and the topoisomerase IV gene (parC/parE). These 
mutations affect quinolone binding sufficiently to permit DNA replication, and an 
accumulation of mutational events in the QRDR can lead to higher levels of quinolone 
resistance [221, 222]. Point mutations in the gyrA gene are the most frequently reported, 
occurring most commonly at the codons 83 and 87 [62, 218, 222-225]. The most common 
point mutations in parC are found at codons 80 and 84 and have been reported only to be 
identified in the presence of gyrA mutations [218, 226]. Mutations in gyrB and parE are 
less commonly identified, and are cited as causing low-level resistance to quinolones when 
present. However, in a recent study by Bansal (2011) in E. coli, a high frequency of parE 
mutations outside of the QRDR, was associated with high-level ciprofloxacin resistance in 
association with multiple gyrA and parC mutations [227].  
In Aeromonas isolates, mutations in gyrA have been identified at codons 83 
(Se83Ile or Se83Arg) and 87 (Asp87Asn) [222, 228, 229]. parC mutations do not 
seem to occur in the absence of gyrA mutations and have been identified at codon 80 
(Ser80Ile).  Arginine and isoleucine point mutation of the gyrA codon 83 seems to be the 
most important for high level quinolone resistance however multiple mutations in this gene 
coupled with mutations in parC may have additive effects resulting in highly resistance 
bacterial strains [222]. Giraud (2004) demonstrated however, that strains with identical 
gyrA/parC point mutations presented different levels of quinolone resistance indicating 
there are multiple factors involved [62]. Mutations in gyrB and parE in Aeromonas, 
associated with quinolone resistance, have not as yet been reported. 
Vibrio species have demonstrated the same type of resistance mechanism with 
(Se83Ile) gyrA  mutations being by far the most common [230-234]. Roig identified an 
additional gyrA mutation (Se83Arg) in V. Vulnificus [232].  parC mutations are 
habitually located at the 85
th
 amino acid with a serine to leucine substitution, however a 
change at amino acid 113 (Ala113Val) has also been identified resulting in elevated 
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MIC’s [232, 233].   This not-withstanding Roig (2009) reported double mutations of gyrB 
in two strains of V. vulnificus (Ala386Thr, Gln412His) and (Glu425Gly; 
Asn438Lys) which were associated with increased resistance in combination with gyrA 
and/or parC mutations. parE mutations have not been identified to date in Vibrio species. 
Until fairly recently, it was thought that mutational resistance along with 
impermeability to the quinolones were the only mechanisms of quinolone resistance. This 
type of resistance is less disconcerting because transmission from one bacterium to another 
is possible only by clonal expansion. Discoveries of quinolone resistance determinants 
such as efflux pumps, antimicrobial modifying enzymes, and proteins which protect 
intrabacterial quinolone targets, as well as plasmid mediated resistance phenotype that had 
been relatively recently reported for the quinolone family, have complicated the picture 
and make the rapid development and spread of quinolone resistance a real possiblity. 
Efflux pumps which reduce intrabacterial concentrations of antimicrobials have 
been shown to make an important contribution to quinolone resistance in Gram-negative 
bacteria and several chromosomally located efflux systems have been identified [235]. 
More recently, a plasmid mediated efflux pump, QepA, coded for by the qepA gene, has 
been characterised in a clinical isolate of E. coli by Yamane (2007) and subsequently in 
other Enterobacteriaceae [236-238]. Giraud (2004) demonstrated indirectly the importance 
of efflux pumps in Aeromonas by comparing MIC’s of bacteria with or without exposure 
to efflux pump inhibitors (EPI’s). The EPI’s reduced the MIC’s by a factor of 2 – 75,000 
times, with the effect being the most pronounced for the third generation quinolone 
ciprofloxacin [62]. 
Although as yet unreported in Aeromonas species, a member of the MATE family 
of efflux proteins with activity for the several antibiotics including the quinolones has been 
reported in Vibrio parahemolyticus [239]. This MDR efflux protein, NorM, demonstrated a 
predilection for hydrophilic quinolones such as ciprofloxacin and norfloxacin resulting in 
increased MIC’s to these compounds, whereas MIC’s to hydrophobic quinolones such as 
nalidixic acid and spafloxacin remained unchanged [239] 
Robiscek (2006) noted a difference in MIC’s to fluorquinolones between different 
populations of E.coli both containing the same plasmid-borne qnrA determinant. Upon 
further investigation they identified an aminoglycoside acetyltransferase (Aac(6’) -Ib-cr) 
which possessed the capacity to modify and inactivate ciprofloxacin [240]. Two mutations 
in the gene led to its capacity to acetylate quinolones and thus contribute to 
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fluoroquinolone resistance. This same gene has been reported in Aeromonas by Picao 
where aac(6’)-Ib-cr was located on a Class 1 plasmid borne integron along with a qnrS 
determinant [137]. 
In 1998 a gene localized on a plasmid coding for quinolone resistance was 
identified in Klebsiella pneumoniae [241]. The qnr gene, codes for a protein which 
protects the topoisomerases from quinolone binding, and five resistance determinant 
groups have been identified to date including qnrA(1-6), qnrB(1-10), qnrC, qnrD and 
qnrS(1&2)  [242-246]. 
This class of plasmid borne resistance determinant was first reported in 
Aeromonadaceae by Cattoir in 2008 where a qnrS2 gene was identified in a mobile 
Aeromonad isolated from water of the Seine River in Paris [247]. This was followed 
closely with a publication by Sanchez (2008) who found the same determinant in a clinical 
A.veronii isolate, and Picao (2008) whom identified the gene in A. allosaccharophila 
isolated from a lake in Switzerland [137, 248]. Cattoir and Picao both identified the qnrS2 
gene as being part of an insertion cassette structure bounded by inverted repeats [137, 247]. 
A vibrionic origin of the qnr determinants was suggested by Poirel (2005) and later by 
Cattoir (2007) [249, 250]. Following an “in silico” analysis of the bacterial genome of 
Vibrio splendidus, prospective qnr genes were cloned and found to increase MIC’s to 
quinolones in recipient bacteria [249]. MIC’s obtained in the various works cited here in 
relation to mutations or genes are presented in Annexs 5 and 6 for Aeromonas and Vibrio. 
Macrolides, lincosamides, streptogramins, ketolides and oxazolidinones (MLSKO 
antimicrobials) 
The MLSKO antimicrobials are bacteriostatic antimicrobials, which include the 
macrolides, lincosamides, streptogramins, ketolides and oxazolidinones, and are composed 
of 14 – 16 membered lactone rings with variable attached amino or neutral sugars [251].  
The lincosamides are an exception, as they contain no lactone ring, but are considered in 
this group because of their mode of action. The MLSKO’s inhibit bacterial protein 
synthesis via a reversible interaction with the 50S subunit of the 70S ribosome, preventing 
translocation of the tRNA. 
There are multiple resistance mechanisms reported for MLSKO’s in Gram-negative 
bacteria. Some Gram-negative bacteria, such as the Enterobacteriaceae, exhibit  innate 
resistance due to impermeability of the bacterium [252]. This does not seem to be 
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universally true for Aeromonas and Vibrio, at least phenotypically, where resistance to 
erythromycin has been reported as ranging from 29.4 – 98% for Aeromonas and 34 – 100% 
for Vibrio species [251, 253-256]. Chromosomally located efflux pumps coding genes in 
Gram-negative and Gram-positive bacteria, belonging to the RND and the ABC or MFS 
families respectively are responsible for efflux macrolide resistance [251, 252]. The vexAB 
genes of V.cholerae code for an RND-family efflux pump protecting the bacteria from bile. 
Bina (2006) noted that vexB mutants were more susceptible to erythromycin indicating its 
non-specific implication in innate macrolide resistance [58]. The inactivation of MLSKO 
antimicrobials has been reported in many bacterial families implicating lyase, transferase, 
phosphorylase and esterase enzymes, this last being recognized in Aeromonas and Vibrio 
[107, 203, 257]. In Gram-negative bacteria, erythromycin esterases which hydrolyze the 
lactone ring of the 14-membered macrolides are responsible for resistance. In Aeromonas 
and Vibrio, erythromycin resistance determinants are rarely reported, however the 
erythromycin esterase gene ere-A2 has been identified as a resistance cassette within class 
1 integrons in both genera [107, 203]. 
 
Rifamycins 
Rifamycins are natural or semisynthetic drugs derived from an actinomycete, 
Amycolatopsis mediterranei and their bactericidal activity is due to the inhibition of RNA 
synthesis due to binding with the DNA-dependant RNA polymerase [258]. This class of 
drugs has greater activity against Gram-positive bacteria and is used primarily for the 
treatment of mycobacterial infections [258]. Gram-negative bacteria are generally 
considered resistant due to impermeability to the drug. Resistance the rifamycins arises via 
two principal mechanisms. The first is by point mutations of the RNA polymerase 
rendering it insensitive to the rifamycins, and the second is enzymatic inactivation of the 
antibiotic with an ADP-ribosylating transferase via the arr gene [259]. In bacteria such as 
M. tuberculosis, the former is by far the most important, but for other bacteria additional 
resistance mechanisms include glycosylation, phosphorylation and ribosylation enzymes 
which inactivate the antimicrobial [258]. As was seen previously for the ere genes, those 
coding for rifamipicin resistance are not frequently encountered. It is likely that research 
has not been directed towards the resistance mechanisms for these classes of drugs because 
they are seldom recommended or used with the genera in question here. Although the 
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presence of these resistance elements has little consequence upon therapy options for the 
genera discussed here, their presence on transmissible genetic elements may serve as a 
reservoir for other human pathogens. In studies by Lee, Picao and Rajpara, either the genes 
arr-2, arr-3 or both were identified as being present in the variable region of class 1 
integrons [107, 109, 137].  
The usage of antimicrobials in aquaculture may represent an exposure risk, to bacteria 
resistant to antimicrobials, especially in imported products. Although significant 
information concerning AMR and causal resistant determinants in Aeromonas and Vibrio 
is available in the literature, there is little data available concerning that found in fish and 
seafood at the retail level in Canada or elsewhere.  The following manuscript describes and 
discusses the methods and results concerning 1) the identification of the targeted bacteria 
(Aeromonas and Vibrio); 2) the determination of the occurrence of phenotypic resistance in 
Aeromonas and Vibrio species found in fish and seafood; 3) and the characterization of the 
causal resistance genes. 
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Abstract 
Antimicrobial use in the aquaculture setting is generally considered low as compared to 
other types of animal production. However, where endemic disease requires frequent 
therapeutic intervention, or in countries where antimicrobial usage is poorly regulated, the 
quantities used may be considerably higher. This may lead to increased occurrence of 
antimicrobial resistance (AMR) in aquaculture products and increased the risk of human 
exposure. Little information is available concerning the occurrence of antimicrobial 
resistance in finfish and seafood available at the retail level in Canada. In this study, 175 
Vibrio isolates were cultured from 323 finfish and shrimp sampled within the framework of 
the Canadian Integrated Program for Antimicrobial Resistance Surveillance. 
Epidemiological cut-off values were estimated for the tetracyclines, folic acid inhibitors, 
quinolones and florfenicol using Normalised resistance interpretation (NRI-ECV) of the 
disk diffusion data and then compared to corresponding MIC distributions and AMR gene 
presence. Gene presence associated with resistance phenotypes was evaluated using PCR 
and microarray analysis.  Vibrio prevalence in finfish and shrimp was 16% and 49% 
respectively, where V. parahaemolyticus was the species most often identified. The NRI-
ECV for tetracycline separated the population into distinct susceptible or wild-type (WT) 
and non-susceptible, non-wild-type (NWT) populations and correctly classified all isolates 
with identified tet resistance genes as NWT. Classification was less clear for SXT, where 
among 8 isolates classified as NWT, six contained genes for resistance to folic acid 
inhibitors (sul2, sul2/dfrA7) and two contained none of the resistance genes, whereas three 
isolates identified as WT by the NRI-ECV harboured sul2, sul2/dfrA7 or drfA5. Fully 
susceptible populations were noted for florfenicol and enrofloxacin, whereas 4 isolates 
were classified as NWT for nalidixic acid and a gyrA mutation was identified in only one of 
these isolates. Reasons for misclassification could include: abnormal inhibition zone 
distributions, suboptimal PCR primers or non-specific probe design, and intermediate 
inhibition zones caused by stepwise decreases of susceptibility due to the accumulation of 
mutation or resistance determinants such as with the quinolones and potentiated 
sulfonamides. NRI analysis was useful in establishing ECVs for four antimicrobial classes 
for Vibrio species using laboratory specific isolates. The results obtained indicated a high 
correlation between isolates classification as WT/NWT and gene presence. 
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1.0 Introduction 
Aquaculture is the fastest growing agri-industry in the world. It currently accounts for 46% 
of the world fish supply and is poised to overtake wild fisheries as the primary fish source 
[260]. Antimicrobial exposure in the aquaculture setting is generally considered low as 
compared to other types of animal production, however, in countries where endemic 
disease requires frequent therapeutic intervention, or in countries where antimicrobial usage 
is poorly regulated, the quantities used may be considerably higher [3]. Antimicrobial 
resistance has been reported in many species of aquatic bacteria in freshwater and marine 
environments including Vibrio. Vibrio species are Gram-negative, mobile, predominantly 
halophilic bacteria that are frequently found in marine systems. Some species are common 
pathogens of cultured marine fish causing septicemia or focal chronic disease and certain 
species can cause severe disease in humans [14-17].  
In both aquacultured animal and human illnesses, antimicrobial therapy may be necessary . 
However, the presence of antimicrobial resistance may decrease the chances of successful 
treatment [23-27].  
Disk diffusion and broth dilution are the most common methods used for susceptibility 
evaluation by clinical laboratories. Approved guidelines have been published by Clinical 
and Laboratory Standards Institute (CLSI) for both methods concerning bacteria isolated 
from aquatic animals [261, 262]. However, the current CLSI breakpoint recommendations 
used to interpret susceptibility of Vibrio, published in CLSI M45-A are adapted from the 
Enterobacteriaceae and may not be appropriate for Vibrio [263]. For example, Vibrio may 
require the addition of sodium chloride for adequate growth, which may affect test 
performance and interpretation. In addition, drug pharmacodynamic and pharmacokinetic 
considerations and clinical effectiveness are elements necessary to the traditional approach 
of ascertaining antimicrobial susceptibility.  At this time, there is a paucity of information 
concerning these aspects for Vibrio species, making susceptibility testing and results 
interpretation a challenge.  
Epidemiologic cut-off values (ECV’s) have traditionally been determined using frequency 
distributions of disk diffusion and minimal inhibitory concentration (MIC) data [264]. This 
technique is based on rigorous adhesion to standard methods, and an inclusion of large 
numbers of isolates (> 300) is recommended. Using recommended susceptibility testing 
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methods, inter-laboratory variability susceptibility determination should be minimal for the 
same isolates. However, some studies have suggested otherwise [265, 266]. Normalised 
Resistance Interpretation (NRI) has been proposed to identify wild-type (WT) and non-wild 
type (NWT) bacterial populations [267, 268]. NRI-ECVs are defined using the normal 
distribution of disk inhibition zones of the population of susceptible isolates to define the 
wild type distribution. The advantages of this technique include generation of lab-specific 
epidemiological cut-off values, autocalibration, reliance on standardized methods 
independent of disc test standards, and therefore independent of interlaboratory variability 
[267]. 
In this study, 175 Vibrio isolates cultured from retail seafood were tested for susceptibility 
to antimicrobials using disk diffusion and broth dilution techniques. Epidemiological cut -
off values (ECV’s) were estimated using NRI of the disk diffusion data and then compared 
to corresponding MIC distributions and antimicrobial resistance gene presence.  
2.0 Materials and Methods 
2.1 Sample collection and bacterial isolation 
Three hundred and twenty three retail seafood samples (164 salmon, 149 shrimp, 6 trout 
and 4 tilapia) were obtained between the 20
th
 of October, 2008 and the 20
th
 of July 2009, 
within the sampling framework of the Canadian Integrated Program for Antimicrobial 
Resistance Surveillance (CIPARS) [42]. They originated from Québec, Ontario, 
Saskatchewan, British Columbia and the Maritimes.  Finfish samples taken included filets 
or steaks (skin-on or skin-off) whereas raw shrimp samples were submitted whole 
deveined. The original retail samples were purchased as fresh, thawed or frozen. 
Approximately 100 grams of each sample were placed individually in 7x12inch sterile 
filtered bags (VWR International, Mississauga, ON) with 225ml of alkaline peptone water 
(APW), (Oxoid, Cambridge, UK) and homogenized by hand for two minutes with 
subsequent incubation at 28
o
C for 18-24 hours. Vibrio species were cultivated and selected 
by inoculating Thiosulfate Citrate Bile Sucrose agar plates (TCBS), (Oxoid, Cambridge, 
UK) with a loopful of the APW enrichment. Two yellow and two blue-green colonies were 
selected and plated onto half TSA + 5% sheep blood (TSA-Blood) + 2% NaCl agar plates 
for further testing. 
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2.2 Bacterial identification 
Putative Vibrio isolates were subjected to an initial panel of tests including: Gram stain, 
motility, oxidase, triple sugar iron + 2% NaCl (TSI), (Oxoid, Cambridge, UK) agar slant 
and 0129 susceptibility (2,4-diamino- 6,7-diisopropylpteridine phosphate, 150mg) (BD-
BBL, Mississauga, Ontario). A putative Vibrio sp. identification was given to those isolates 
found to be Gram-negative, motile, oxidase positive, sensitive to 0129 and demonstrated an 
acid/acid or alkaline/acid reaction without the presence of gas or H 2S in TSI agar slants. Up 
to two isolates per positive sample were preserved in tryptic soy broth (TSB) + 50% 
glycerol at -82
o
C for further testing. 
One hundred and eighty five putative Vibrio sp. isolates were then identified using the 
Vitek2
®
 identification system following manufacturer’s protocols (bioMérieux, Marcy 
l'Etoile, France). This identification was confirmed via amplification of the ribosomal 
polymerase subunit gene rpoB as previously described, with some modifications [269]. 
PCR amplification was performed in 25 μl
 
containing; 2ul 10X PCR buffer, 0.08mM 
dNTPs, 0.2mM MgCl2, 10 pmol of opposing primers,  1.25U Taq polymerase (New 
England Biolabs, Pickering, Ontario) and from 50-100ng of DNA template. A temperature 
of 56
o
C was used during the hybridization step. V. alginolyticus ATCC17749, V. fluvialis 
ATCC33812, V. parahaemolyticus ATCC17802 and V. vulnificus ATCC27562 were used 
as controls. The same primers were used for subsequent sequencing reactions of the 
approximately 540bp PCR products. Sequencing was performed by the Plate-forme 
d'analyses biomoléculaires (PAB), Université Laval. Identification was made using the 
National Center for Biotechnology Information (NCBI) basic local alignment search tool 
(BLAST) [270]. Identification to the species level was defined as an rpoB sequence 
‘Maximum identity score’ of ≥99% with that of strain sequences in GenBank whereas 
identification to the genus level was defined as those isolates having a ‘Maximum identity 
score’ of ≥97%. A score of lower than 97% was considered as a failure of identification 
[271]. 
2.3 Antimicrobial susceptibility testing 
All 185 isolates were tested for antimicrobial susceptibility by broth microdilution (MIC) 
and by disc diffusion using methods for aquatic organisms published by CLSI (M42-A, 
M49-A).  Media supplemented with additional salt was not used. For MIC determination, 
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the ARIS automated system of Sensititre
TM
 (Trek
TM
 Diagnostic System Ltd) with a custom 
aquatic plate was used, containing (MIC range in  µg/ml in parenthesis): enrofloxacin 
(0.002-1), florfenicol (0.03-16), oxalinic acid (0.004-2), oxytetracycline (0.015-8) and 
sulfamethoxazole/trimethoprim (0.015/0.3-1/19). Antimicrobials evaluated by disk 
diffusion included (antimicrobial disc content in µg in parenthesis): enrofloxacin (5), 
florfenicol (30), nalidixic acid (30), sulfamethoxazole/trimethoprim (23.75/1.25), and 
tetracycline (30)  (BD-BBL, Mississauga, Ontario). Incubation temperature for all testing 
was 28
o
C. Quality control for both testing methods was performed using Escherichia coli 
ATCC 25922 and Aeromonas salmonicida ATCC 33658.  
2.4 Detection of antimicrobial resistance genes 
Detection of individual antimicrobial resistance determinants by PCR (tet (A), (B), (C), (D) 
& (E)), florR, sul1, sul2, qnr A, B, and S and gyrA/parC mutations was performed to 
validate the NRI-ECV’s. The primers utilised are presented as supplementary information 
in Table S1. Identical amplification reactions were used for floR, sul1 and sul2 with  2.0 µl 
of 10X PCR Buffer, 0.08mM dNTPs, 0.25mM MgCl2, 10 pmol of each primer, 1 U of Taq 
DNA polymerase (NEB) and 50-100 ng of template DNA in a total volume of 20 µl. 
Briefly, the temperature cycles for PCR used were: floR: initial denaturation (94°C, 5 min), 
35 polymerization cycles (94°C for 30s, 60°C for 30s and 72
o
C for 30s), final elongation at 
72°C for 7 min; sul1: initial denaturation (95°C, 5 min), 25 polymerization cycles (95°C for 
30s, 55°C for 30s and 72
o
C for 40s) final elongation at 72°C for 7 min;   sul2: initial 
denaturation (95°C, 5 min), 35 polymerization cycles (95°C for 30s, 62°C for 30s and 72
o
C 
for 45s) and final elongation at 72°C for 7 min. All tet genes were amplified using identical 
amplification reactions and PCR conditions. The PCRs consisted of 2.0 µl of 10X PCR 
Buffer, 0.08 mM dNTPs, 0.14 mM MgCl2 10 pmol of opposing primers, 1 U of Taq DNA 
polymerase (NEB) and 50-100 ng of template DNA, in a total volume of 20 µl. The PCR 
conditions included an initial denaturation step (95°C, 5 min), followed by 35 
polymerization cycles (95°C for 30s, 62°C for 30s and 72
o
C for 45s) and final elongation at 
72°C for 7 min. Amplification of qnrA, qnrB and qnrS genes was undertaken utilizing a 
multiplex PCR as previously described [272]. The gyrA and parC genes were amplified 
using conditions described previously using the gyrm1-2, parm1-2 primer pairs [231]. The 
same primers were used for subsequent sequencing reactions of the approximately 500bp 
PCR products. Comparison to phenotypically susceptible isolates of the same genera was 
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performed to characterize mutations in the quinolone resistance determining region 
(QRDR).  
Eleven isolates were further examined for the presence of resistance genes using microarray 
analysis as described by Bonnet (2009) [273]. Isolates were selected to confirm results, and 
to examine non-susceptible phenotypes for which no resistance genes were identified by 
PCR. The majority of the probes were designed based on gene sequences found in E. coli. 
Twelve probes were added to identify AMR genes not already present on the microarray. 
Information concerning the probes used on the microarray is available as supplemental 
information (Table S2). 
2.5 Statistical analysis 
The calculation of the Epidemiological Cut-Off Value (ECV) for the interpretation of 
susceptibility of isolates was accomplished using NRI of disk diffusion data as previously 
described [267, 274]. For the NRI calculations, peak values were established using four 
points rolling averages, and a plot of seven probit values versus zone size was used to 
identify the means and standard distribution of the susceptible population. ECV’s were set 
at 2.5 standard deviations from the mean. Those isolates demonstrating inhibition zone 
sizes smaller than the the calculated ECV are considered Non-wild type (NWT) and those 
above wild-type (WT). All statistical analyses and graphics were generated in Microsoft 
Excel (2007) and the R program for statistical computing and graphics (open source 
software version 2.11.0). 
3.0 Results 
3.1 Bacterial isolation and identification 
Of the 323 seafood samples examined, 185 putative Vibrio sp. isolates were recovered from 
45 (15.6%) and 113 (48.9%) of the finfish and shrimp samples, respectively. Ninety-five 
percent of these (175/185) were confirmed as Vibrio species with the rpoB sequencing: V. 
parahaemolyticus (n = 86), Listonella (Vibrio) anguillarum (n = 45), Vibrio sp. (n = 27); V. 
alginolyticus (n = 7), V. metschnikovii (n = 5), V.cholerae, (n = 2); V. harveyii, (n = 2), V. 
vulnificus, (n = 1).  
3.2 Tetracycline susceptibility 
The zone size distribution for 175 Vibrio isolates to tetracycline (TET) is shown in Fig.1a. 
The mean zone size for the susceptible populations as estimated using NRI analysis was 
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27.9 mm with a standard deviation of 2.8 mm and an ECV of ≥20 mm. The use of this ECV 
enabled the classification of 10/175 (5.7%) isolates as NWT for TET with inhibition  zones 
measuring from 6 – 17 mm. The disc diffusion zone size results of 174 isolates for 
tetracycline were compared with MIC results in Fig.2. The bimodality of the population is 
evident, with 4 dilutions (from 1-8μg/ml) separating the two populations. The genes tet(B), 
tet(A) and tet(E) were identified in 4, 2 and 1 isolates, among ten NWT isolates, 
respectively, corresponding to zone sizes of 6 - 17mm and MIC’s of  >8 μg/ml. The MIC 
for all 3 isolates which were negative for tet genes was >8 μg/ml. 
3.3 Florfenicol susceptibility 
The zone size distribution for 175 Vibrio isolates to florfenicol (FFC) is presented in 
Fig.1b. The mean zone size for the susceptible populations as estimated using NRI analysis 
was 31.8 mm with a standard deviation of 3.0 mm and an ECV of ≥24 mm. Only one 
isolate (1/175, 0.6%), with a zone size measuring 21mm was considered as NWT. When 
comparing disk diffusion zone sizes with corresponding MIC’s in Fig. 2, an unimodal 
susceptible population is suggested. The single isolate which was classified as NWT by 
NRI, demonstrated an MIC of 0.5μg/ml. The flo-R gene was not found in this unique isolate 
identified by the NRI-ECV.     
3.4 Trimethoprim-sulfamethoxazole susceptibility 
The zone size distribution of Vibrio isolates for trimethoprim-sulfamethoxazole (SXT) is 
presented in Fig.1c. The mean zone size for the susceptible populations as estimated using 
NRI analysis was 29.9 mm with a standard deviation of 3.5 mm and an ECV of ≥21 mm. 
Using this ECV, 8 of 175(4.6%) isolates were classified as NWT for SXT with inhibition 
zones measuring from 12-18 mm. However, three isolates containing resistance genes 
(sul2, dfrA5, dfrA7/sul2) were classified as WT with regards to SXT by the NRI-ECV. 
When disc diffusion zone size results are compared with MIC’s (Fig.2.), a bimodal 
distribution is present with a separation of the two populations at the 0.25μg/ml dilution. 
Six  NWT isolates harbouring the gene sul2 or the combination dfrA7/sul2 had MIC’s from 
0.5-2 μg/ml, whereas the 3 WT isolates carrying dfrA5, dfrA7/sul2 and  sul2  were found at 
MIC’s of  0.03, 0.125 and 0.5 μg/ml respectively.  
3.5 Quinolones susceptibility 
The zone size distribution of Vibrio isolates for nalidixic acid (NA) and enrofloxacin 
48 
 
(ENO) are presented in Figs.1d and 1e. The mean zone size for the susceptible populations 
as estimated using NRI analysis was 32.9 mm with a standard deviation of 5.4 mm for NA 
and 34.7 mm with a standard deviation of 5.6 for ENO, resulting in ECV’s of ≥19 and ≥20 
mm, respectively. The use of these ECVs enabled the classification of 4/175 (2.3%) isolates 
as being NWT for NA and 0/175 (0%) isolates as WT with respect to ENO. The disc 
diffusion zone size results of 174 isolates are compared with MIC results in Fig.2. The 
ENO distribution is unimodal, as compared to the comparison of the disc diffusion zone 
sizes of NA and MIC’s of oxolinic acid where a bimodal distribution is evident with two 
dilutions (1-2 μg/ml) dividing the two populations. The point mutation gyrASe83-Ile was 
identified in one of the five isolates at an MIC of 4 μg/ml, and was identified as NWT by 
the NRI-ECV. 
3.6 Epidemiologic cut-off values for different species subgroups 
Seven species of Vibrio were identified in this study with V. parahaemolyticus (86) being 
the most prevalent. When the NRI-ECV for all Vibrio sp. was compared to the NRI-ECV 
calculated for the inhibition zone diameters of V. parahaemolyticus the ECV’s are similar 
for both groups with the exception of SXT (see Table 1) where 5 NWT isolates were 
reclassified as WT. Among the reclassified isolates, one harboured sul2 and another, a 
sul2/dfrA7 gene combination. Only those isolates with small inhibition zone diameters (12-
13 mm) remained classified as NWT, all positive for sul2.  
4.0 Discussion 
The Epidemiologic cut-off values (ECVs) derived from NRI analysis, in general, agree well 
with the distribution of the zone diameter and MIC data for the antimicrobials and 
resistance genes. The NRI-ECV for TET separated the population into distinct WT and 
NWT populations, and classified all isolates with identified resistance genes as NWT. The 
presence of TET resistance genes has been associated with radically decreased 
susceptibility in several publications, which can result in widely separated bimodal 
distribution as seen here [161, 177, 275]. This could facilitate agreement of distribution 
data with NRI-ECV, and a similar ECV may have been derived from observation of the 
distribution data.   
Among eight isolates classified as NWT by the NRI-ECV for SXT, six contained genes for 
resistance to folic acid inhibitors, but in two no resistance genes were identified. This could 
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indicate poor sensitivity of PCR (primer or probe design for the targeted gene) or 
misclassification by the NRI-ECV. The presence of dfr variants not yet described is also a 
possibility. Additionally, the microarray used in this study was designed for E. coli, it is 
also possible that the genes used for probe design were different enough from those found 
in Vibrio to make detection difficult. Three isolates harbouring genes coding for resistance 
to folic acid were classified as WT. It is generally considered that resistance to SXT 
requires the presence of genes coding for both sulfonamide and trimethoprim resistance. If 
this is the case, in those isolates where only a sul or dfr gene were identified, it would 
suggest that an additional gene remains unidentified and in the case where both sul and dfr 
genes were identified, there may have been a laboratory error. If isolates contain either sul1 
or drfA but not both, the inhibition zone size data may be between fully susceptible and 
fully resistant thus making interpretation difficult using an ECV based on inhibition zone 
size. As suggested by others [276], the use of single agents rather than drug combinations 
for susceptibility testing may help resolve some of the discrepancies observed here. The 
zone diameter distribution for SXT was not normal with our dataset, and this may also 
affect the NRI-ECV calculation.  
Laboratory error or variability could also be responsible for the misclassification, and has 
been reported by other authors [265, 277, 278]. The inhibition zone size measurements are 
made to the nearest mm (+/- 1mm), which could change the susceptibility interpretation for 
isolates on or near the ECV as is the case with two of the isolates in the SXT distribution. 
This was echoed by Barry (1974) discussing the role of standardisation in disk diffusion 
techniques [279]. Trailing endpoints and fuzzy zones are also associated with susceptibility 
measurements of potentiated sulfonamides, and this may contribute to their imprecision 
[280].    
The classification of quinolones using NRI-ECV’s demonstrated a relatively low frequency 
of resistance, where only four isolates were found resistant to NA and a gyrA mutation was 
identified in only one of these isolates. When inhibition zones and MIC’s were compared, a 
bimodal distribution was present with the NA/OXO data, however, the same was not true 
for ENO where only a susceptible population was identified (Fig.1&2). Outliers were noted 
for NA/OXO at dilutions of 0.015 and 4μg/ml (NA/OXO), and for FFC at 0.5μg/ml (F ig.2). 
Misclassification was likely due to the location of the isolate in the population distribution 
and the absence of resistance genes or mutations. An ECV was established for ENO in spite 
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of the absence of low or non-susceptible isolates, one of the advantages of using NRI. 
However, the setting of the ENO NRI-ECV was ambiguous with the Vibrio dataset. When 
analyzing the four points rolling averages of ENO, there were three peaks which could have 
been used to position the normalised susceptible population lending an element of 
subjectivity. This subjectivity may lead to the misclassification of isolates as falsely 
susceptible to ENO using the NRI-ECV, as has been previously reported  [266].  In studies 
by Ruane et al. (2007) and Rodiguez-Avial (2005), a high level of correlation between zone 
sizes for oxalinic acid and ENO was noted, indicating probable cross-resistance [266, 281]. 
When the inhibition zone size data derived from our data are compared for NA and ENO, a 
similar linear relationship is noted, also indicating probable cross-resistance (Fig.3). The 
previously mentioned authors further suggest a first generation quinolone could be used as 
a reporter for all quinolone resistance [266, 281]. Although using a reporter quinolone such 
as NA may classify isolates as falsely non-susceptible to ENO, this would have less of an 
impact on treatment outcome than falsely classifying isolates as susceptible. The use of a 
reporter first generation quinolone for resistance evaluation may be useful until a wider 
sample of isolates with more variable and higher resistance to ENO can be evaluated. 
However, the recent discovery of mobile quinolone resistance elements which have a 
greater activity for fluoroquinolones than for quinolones, such as the aac(6')-Ib-cr gene, 
may make this extrapolation questionable [282].     
Species-specific breakpoints have been developed for many important bacteria causing 
diseases in human and animals permitting improved discrimination of susceptible and non-
susceptible populations [283, 284]. V. parahaemolyticus is the species most often 
associated with human illness in the United States and it was the most predominant species 
identified in this study [285]. A species specific NRI-ECV was calculated for V. 
parahaemolyticus to see if there were differences in WT/NWT classification and gene 
presence, particularly for SXT. Using the species-specific ECV, five additional isolates, 
two containing resistance genes were reclassified as WT, which indicates that the ECV 
specific to V. parahaemolyticus may be erroneous. It has been shown that precision of NRI-
ECVs increases and standard deviations decrease with larger sample sizes numbers [286]. It 
could be argued that the sample size was not sufficiently large to allow for accurate NRI-
ECV calculation. The NRI calculation used the high-zone side of the susceptible population 
to reconstruct the susceptible peak and set the ECV and assumes a normal distribution of 
51 
 
WT isolates. The SXT distribution of inhibition zone diameters for V. parahaemolyticus in 
this study was irregular, and likely the cause of the differences. Using larger samples sizes 
with improved coverage of the whole range of susceptibility resulted in improved 
interpretation.  
 
The majority of current publications concerning antimicrobial resistance in Vibrio use CLSI 
breakpoints to evaluate susceptibility. When CLSI breakpoints for tetracycline and the 
fluoroquinolones were compared with NRI-ECV’s, all isolates were classified identically. 
For SXT, however, three isolates were re-classified as susceptible by CLSI, containing 
dfrA7/sul2, dfrA5, and sul2. According to CLSI M45-A, for SXT, an MIC of ≤ 2μg/ml 
would indicate a susceptible isolate. However, Fig. 2 would suggest that when using the 
NRI-ECV, isolates with SXT MIC’s of 0.5 - 2 μg/ml should be considered non-susceptible. 
And in fact, five of the isolates in this MIC range contained either sul2 or a dfrA7/sul2 gene 
combination. Using the CLSI MIC or disk diffusion breakpoints could result in the 
misclassification of some isolates carrying resistance genes. 
To conclude normalised resistance interpretation analysis was useful in establishing ECVs 
for Vibrio species using laboratory specific isolates. It permitted the establishment of ECVs 
for four antimicrobial classes, resulting in an excellent classification of isolates as WT or 
NWT with associated gene presence. Among the quinolones tested, the interpretation with 
NRI-ECVs was least ambiguous with NA. Due to the linear correlation of zone diameters 
between the two quinolones, these results suggest that NA could be considered as a reporter 
for quinolone non-susceptibility.  
 
6.0 Supporting Information 
Table S1: Primers for simple PCRs used in this study.  
Table S2: AMR probes present on the microarray and reference genes, used in this study.  
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Figure 1:  Histogram of inhibition zone diameters of Vibrio sp. population 
Note:  The calculated NRI-ECV value for each antimicrobial is indicated by the vertical 
dotted black line.
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Figure 2:  Comparison of MIC and disc diffusion zones for Vibrio sp. 
isolates 
MIC and inhibition zone values for each antimicrobial are found on the x-axis and y-axis 
respectively. The width of the plot represents sample density and the extremities, the 
minimum and maximum values. The center point indicates the median and the quartile 
values are found at the extremities of the internal black bar. The calculated NRI-ECV value 
for each antimicrobial is indicated by the horizontal red-dashed line. 
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Figure 3:  Comparison of the zone diameter distributions of Nalidixic acid  
(NA) and Enrofloxacin (ENO).  
 
 
 
 
Table I:  NRI-ECVs calculated for all Vibrio sp. and the 
V. parahaemolyticus subpopulation 
Antimicrobial
a
 All Vibrio (n=175)
b
 V. parahaemolyticus (n=86)
b
 
TET ≥ 20 ≥ 21 
FFC ≥ 24 ≥ 22 
SXT ≥ 21 ≥ 14 
NA ≥ 19 ≥ 22 
ENO ≥ 20 ≥ 17 
a
Antimicrobial abbreviations:  TET; tetracycline, FFC; florfenicol, SXT; sulfamethoxazole-
trimethoprim, NA; nalidixic acid, ENO; enrofloxacin 
b
Isolates with a zone diameter less than the ECV indicated are considered non-susceptible. 
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General discussion 
The principle objective of this project was to generate information concerning AMR 
in Aeromonas and Vibrio species derived from fish and seafood while evaluating the 
methods used at various steps, from bacterial identification to antimicrobial susceptibility 
testing, to evaluate the necessity of the inclusion of those genera into a nat ional 
antimicrobial resistance surveillance program in Canada. Aeromonas and Vibrio are 
ubiquitous in the aquatic environment, have the capacity to cause disease in animals and 
humans, and possess a genetic basis for antimicrobial resistance which is shared by 
important human pathogens such as E. coli.  Multiple authors have also described their 
capacity for inter and intra-genic transfer of resistance determinants [4, 6, 39, 84]. Several 
publications describe the presence of E. coli and another human pathogen, Salmonella, in 
seafood [287-290]. Bacteriological isolation performed in parallel to this study indicated an 
overall prevalence in seafood of 27.2% and 2.5% for E. coli and Salmonella, respectively 
[287-290]. However, these genera are not considered as being commensals in the aquatic 
environment as are Aeromonas and Vibrio, their presence being rather a consequence of 
fecal contamination of either the culture methods or more likely the processing and retail 
chain [291, 292]. Therefore, the choice of examining Vibrio and Aeromonas in this study 
was made not only based on the genetic promiscuity of AMR genes and direct impact on 
human health, but also due to its presence in the aquaculture environment where AMR may 
be selected for by aquaculture practices, particularly in those countries where antimicrobial 
usage is poorly regulated [3]. 
 Identification of Aeromonas and Vibrio spp. 
Aeromonas and Vibrio were members of the same family until 1986 when they were 
separated by Colwell following analysis of ribosomal DNA sequencing and DNA/DNA 
hybridization results [9]. Both genera of bacteria, therefore, share many qualities including 
morphological, growth and habitat characteristics. Detailed biochemical identification keys 
for Aeromonas and Vibrio species have been published by Alsina (1994) and Abbott (2003) 
and various commercial systems have been used for definitive identification. [293, 294]. 
The advantages of biochemical characterisation is its relative simplicity, rapidity and the 
capacity to utilise these techniques with a minimum of laboratory equipment and 
incorporation into a surveillance program would likely be less complicated than a series of 
biomolecular manipulations.  However, they are biochemically pleiomorphic, and while 
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identifying bacteria to the genus level can be accomplished relatively easily, speciation 
with biochemical tests can be extremely challenging and confusion between the two genera 
remains a problem for routine identification in diagnostic laboratories [295-298]. The use 
of biochemical screening tests before identification can help orient the identification, but 
final identification to the species level seems need to be confirmed [299, 300].  
Identification in this study was attained in a stepwise method starting with five screening 
tests used to identify presumptive Aeromonas sp. and Vibrio sp. isolates including: growth 
on selective media (Aeromonas agar/TCBS), triple sugar iron agar (TSI), oxidase, Gram 
stain, and mobility. This was followed by biochemical identification and then confirmed 
using a genetic technique. Several commercial biochemical panels have been applied to the 
identification of Aeromonas and Vibrio species and some examples include the API-20 
system (bioMérieux), Biolog (Biolog inc.), or Vitek2 (bioMérieux) [301, 302].  These 
systems use a variable number of miniaturized tests tubes or microwells containing 
different reagents which determine the metabolic capabilities of bacteria. When these 
results are compared with a database, the genus and species of the bacteria examined is 
identified. The Vitek2 was selected here principally because of its availability and 
extensive battery of biochemical tests. Multiple biomolecular techniques have been 
developed to help in the speciation of Aeromonas and Vibrio including: sequencing of 
housekeeping genes, restriction fragment length polymorphism of selected genes, rep-PCR 
methods and whole protein analysis [303-307]. In this study, initial attempts were made to 
speciate Aeromonas and Vibrio by sequencing an approximately 500 bp fragment of the 
16S rDNA as described by Giovannani [308]. However initial trials failed to discriminate 
isolates in the Genbank database. It is possible that the fragment did not cover a variable 
region of 16S rDNA permitting identification or perhaps sequencing of the whole gene 
would have been necessary, as other authors seem to be able to differentiate between 
isolates and species with success [271, 309, 310].  Following recommendations by Dr 
Antonella Demarta from the Istituto Cantonale di Batteriologia, Bellinzona, Switzerland, 
the amplification of the housekeeping rpoB gene followed by sequencing, was utilized for 
definitive speciation of the isolates [269]. The choice of this gene for bacterial 
identification is also echoed by Mollet (1997) [311]. This choice was verified by the 
identification of four ATCC strains of Aeromonas and Vibrio, and in certain cases, the 
analysis of the rpoB sequences permitted identification of not only the species, but the 
specific ATCC control strain used within the Genbank repository. Two hundred and twelve 
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and 182 isolates were identified as Aeromonas sp. and Vibrio sp. respectively by the initial 
biochemical screening tests previously described, followed by confirmatory rpoB and 
Vitek2
®
 analysis. 
The Kappa coefficients for agreement between rpoB and Vitek2
®
 were quite low 
and indicate slight or no agreement between the two tests especially for Vibrio (Annex 9).  
If rpoB sequencing were to be considered as the gold standard for identification, when 
comparing the two identification techniques, the sensitivity (Se) and the specificity (Sp) of 
the Vitek2
®
 identification can be calculated. 
The Se for Aeromonas genera identification was quite good at 96%, and is similar to 
that reported for Gram-negative bacteria by other authors, whereas the specificity would 
have allowed 57% false positive results [312, 313].  The Se and Sp for speciation of 
Aeromonas were both quite low, and would have resulted in 88% false positive (identifying 
as Aeromonas when it was not) and 68% false negative (identifying as other than 
Aeromonas when it was) results respectively. The Se and Sp values for Vibrio identification 
were 40% false positive and 29% false negative at the genus level and 76% false positive 
and 29% false negative at the species level.  These results are in general higher than that for 
Aeromonas with the exception of Aeromonas genera Se (96%).   
Other authors have described poor performance of biochemical methods as 
compared to genetic identification.  Borrel (1997) found a 72% agreement at the species 
level when RFLP analysis of the 16S rDNA was compared with biochemical identification 
scheme based on Abbotts (2003) [294, 300] and when Castro-Escarpulli’s (2003) compared 
Vitek2 results with the same biomolecular technique, the author found that only 28.5% 
were speciated correctly, if we accept the genetic technique as gold standard. In a study by 
Sanjuan (2009) which compared different biochemical identification systems and their 
capacity to identify confirmed set of Vibrio vulnificus isolates, he demonstrated that 
different API
®
 test strips, API20NE
®
 and API20E
®
, correctly identified 0 and 60% of the 
isolates, respectively, whereas Biolog
®
 succeeded in identification of 84% of the isolates 
[301]. Even though biochemical diagnostic tests have likely evolved since the publication 
of these studies, the results are similar to what was found here in that, identification to the 
species level using biochemical methods appears to be unreliable. 
Although the sequencing of rpoB for speciation is a commonly reported technique 
in the literature and functioned well here with control strains, it was not validated as a gold 
standard in this project, and should be, before using as a definitive identification tool.  If 
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however, speciation is a goal, then presumptive identification of isolates using screening 
tests should be followed by a definitive biomolecular technique, which is a sentiment 
echoed by other authors [300, 306].  
Susceptibility testing of Aeromonas and Vibrio isolates 
Since the first recognition of Aeromonads resistant to sulfonamides by Snieszko and 
Bullock in 1957, the presence of AMR in these bacteria in aquaculture, its environment and 
in aquacultured animals worldwide has been well documented [8, 91, 161, 173, 254, 314-
316]. Although this study examined more closely those classes of antimicrobials commonly 
used in aquaculture (tetracyclines, potentiated sulfonamides, phenicols (florfenicol) and 
quinolones), phenotypic resistance to all major classes of antimicrobials have been 
described for Aeromonas and Vibrio [106, 136, 157, 256, 257, 317]. 
There are currently no universally accepted epidemiologic cut-off values (ECV’s) which 
have been derived specifically for the Aeromonas and Vibrio genera. Those that are 
available have been adapted by CLSI (Clinical and Laboratory Standards Institute) from 
breakpoints used for Enterobacteriaceae, and in consideration of this work, only those 
concerning sulfamethoxazole-trimethoprim, tetracycline and the quinolones (enrofloxacin) 
were of interest as they relate to antimicrobials used in aquaculture. Antimicrobial 
susceptibility testing methods have been proposed by CLSI for aquatic bacteria, but not 
interpretive criteria [261, 262]. According to CLSI, development of interpretive criteria 
requires large datasets (300+), rigorous adherence to standardised conditions including 
control strain measurements, clinical validation and an assumption that MIC measurements 
are gold standard from which acceptable error is estimated [264]. Our datasets contained 
199 Aeromonas and 175 Vibrio confirmed isolates, and used an incubation temperature of 
28
o
C rather than 35
o
C as with CLSI published breakpoints (M45-A). Additionally, there is 
currently a lack of control strain measurements for mobile Aeromonads and Vibrio, all 
making interpretive criteria development difficult [263]. To circumvent these limitations, 
Normalised Resistance Interpretation (NRI), based on disk diffusion distributions of the 
experimental population [267, 274] was used to evaluate susceptibility. This method, is 
internally calibrated using the high zone side of the susceptible peak of isolates of the 
experimental population and is useful when evaluating rarely isolated organisms where 
numbers may not permit traditional ECV calculation [286].  Even with as few as 10 
isolates, susceptibility interpretation could be improved using this technique [286]. When 
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the bacterial populations were evaluated using the NRI-ECV’s, overall resistance was low, 
with resistance to tetracycline being the highest for both Aeromonas and Vibrio (see Article 
1 and Annex 10). Tetracyclines were among the earliest antimicrobials available for use in 
aquaculture, and chronic usage may be related to this prevalent phenotype. A recent survey 
of aquaculture-allied professional (Tusevlak et al, in prep) indicated that tetracycline would 
still be the most frequently used antimicrobial world-wide, all species confounded [318]. In 
contrast to our results, several recent publications concerning resistance in marketed 
seafood show higher levels of resistance to potentiated sulfonamides, tetracyclines and 
quinolones [302, 319-322]. This discrepancy may have many sources.  If cut-off values 
used for susceptibility interpretation are erroneous, over or under estimation of true AMR 
prevalence may be the result, as discussed previously.  Additionally,  the identification of 
the bacterial isolates could be called into question in light of the results previously 
discussed. Other obvious explanations for the different AMR prevalences observed 
certainly include differences in the seafood species investigated, seafood of various origin 
(country or region, aquaculture versus wild capture, husbandry techniques, etc.), or a biased 
sampling scheme.   
When a sampling scheme requires retaining more than one isolate per sample, 
adjusted measures of prevalence may be required to avoid overestimating AMR prevalence. 
In this project, a duplication of AMR phenotypes in isolates of Aeromonas or Vibrio 
recovered from the same sample were investigated using rep-PCR (Novakova, 2009) to 
assess for multiple isolates of the same strain. Nonsusceptible Aeromonas isolates were 
identified in 21 fish/seafood samples. In six of the samples the two isolates retained 
demonstrated the same AMR phenotype. According to rep-PCR analysis, the isolate pairs 
from four of the 21 samples were clonal. Similarly, for Vibrio, clonal pairs were found in 
three of 15 fish/seafood samples where the isolate pairs selected exhibited the same AMR 
phenotype.  In consideration our data, if only one isolate was selected for identification and 
AMR determination and in 50 percent of the cases, (a coin toss), the susceptible isolate was 
chosen over that presented a resistant phenotype, the overall prevalence of samples 
exhibiting some type of AMR would drop from 17.2% to 14% for Aeromonas and 18% to 
10% for Vibrio. 
The sampling of seafood for this project concentrated principally on shrimp and 
salmon, although small quantities of other finfish such as trout and tilapia were also taken 
when salmon was not available. The large scale of geographical origine of the sample, and 
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the eventuality of manipulation associated cross contamination, may participates to explain 
the flora on the samples. An effort was made to obtain fresh non-frozen seafood so as to 
avoid microfloral changes associated with freezing [323]. Within the context of our 
sampling, 85% of the sampled shrimp were sold as frozen or thawed products,  whereas for 
sampled finfish, only 20% was sold frozen, with 12 and 20% of these products having an 
unknown preservation status, respectively. The freeze/thaw stress which may occur during 
transport and store display has been shown to result in curing of plasmids carrying 
antimicrobial resistance determinants [324, 325]. A decreased resistance to rifampicin was 
also noted in Campylobacter jejuni following freezing due to purported changes in the 
bacterial membrane [326]. Therefore preservation by freezing could translate to changes in 
AMR genotypes and phenotypes and may partially explain the low AMR prevalence 
identified in this work. In contrast however, Escarpulli (2003) was able to demonstrate high 
levels of resistance to sulfamethoxazole-trimethoprim (49%), tetracycline (44%) and 
ciprofloxacine (42%) in Aeromonas sp. a study of frozen tilapia in Mexico [302]. 
Therefore, from published information it is difficult to define the importance of freezing on 
AMR prevalence. 
 The quality and safety of transported fresh and/or frozen fish and seafood is 
ensured by the use of temperature controlled supply chains (or “cold chains”) [327]. 
Failures in this chain may favour the growth of certain Aeromonas and Vibrio species 
identified in this study which are capable of growth at temperatures ranging from 0-45
o
C 
[10]. These psychrophilic or mesophilic bacteria may increase in numbers in food products, 
even though their initial concentrations may have been negligible [328, 329]. This was 
examined by Begum (2010), where the growth of Pseudomonas, a bacterial indicator of 
spoilage, was more frequent in market conditions where there were poor handling, 
improper storage and sanitary conditions as opposed to modern supermarkets where quality 
controls are in place.  
Identification of resistance genes in Aeromonas and Vibrio 
In the course of this project the detection of resistance determinants in isolates 
classified as non-susceptible using the NRI-ECV was achieved using PCR and microarray 
analysis. The advantage of this approach was the combination of the sensitivity of PCR 
with the wide spectrum of AMR probes present on the microarray, and interesting 
differences were noted. As mentioned previously, tetracycline resistance was the most 
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common phenotype identified for both Aeromonas and Vibrio. Among 13 Aeromonas 
isolates carrying tet(E) identified by microarray analysis, only 46% were identified by PCR 
and repetition of the simple PCR for tet(E) did not detect those genes detected by 
microarray. In contrast, the presence of floR, sul1 and intI1 in Aeromonas and sul2 in 
Vibrio were signalled by PCR, but were not found with the microarray. Differences in gene 
detection by both methods is likely associated with the variability of gene sequences in 
Aeromonas/Vibrio and differences between these species and E. coli, the species for which 
the microarray was developed.  
Genes in the bla family were among the most commonly identified by microarray 
analysis (Annex 12). A high level of β-lactam resistance is common in Aeromonas due to 
chromosomally located inducible β-lactamases and this was no different in the current 
study [330]. A resistance phenotype that would normally be associated with an acquired β-
lactamase gene would be masked by this innate resistance. A similar high level of 
phenotypic resistance in Vibrio isolates was also recognized which would suggest a similar 
resistance mechanism. Although β-lactam antimicrobials are not commonly used in the 
treatment of diseased aquaculture organisms except in the case of certain Gram-positive 
pathogens, this innate resistance becomes important when discussing bacterial genera of the 
aquatic environment acting as a reservoir of resistance determinants. For example, the β-
lactamase classes B, C and D are commonly associated with innate resistant in Aeromonas 
[48].  The phenotypic resistance conferred by these chromosomally located genes may 
mask the presence of mobile genetic resistance elements which code for β-lactamases with 
similar activity. When selected Aeromonas and Vibrio isolates were subjected to microarray 
analysis, several putative mobile β-lactamase genes were identified including blaVIM-2, 
blaFOX-2, blaTEM, and blaSME1, some being novel variants for these genera. Their genomic 
localisation was not investigated, but these are commonly associated with class 1 integrons 
or other mobile gene platforms [135, 153, 331, 332].  In seven Aeromonas isolates, 
decreased susceptibility to ampicillin (AM), ampicillin-clavulanic acid (AmC) and 
cefoxitin (FOX) was associated with the presence of a blaVIM2/blaSME1 combination, blaFOX2 
or blaTEM, whereas 3 isolates containing either blaTEM or blavim2/blaSME/blaTEM demonstrated 
a phenotype of decreased susceptibility to AM/AmC.  Decreased susceptibility to 
AM/AmC/FOX and ceftriaxone (CRO) was identified in two Vibrio isolates, the presence 
of where blaVIM2/blaSME could explain the extended spectrum of β-lactamase activity. In 
Aeromonas, the phenotypes could be explained simply by the expression of chromosomal 
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β-lactamases, even though putative mobile genes were identified. Therefore, innate 
resistance does not seem to be an impediment for the acquisition mobile resistance 
determinants and may in fact hide the importance of these genera as gene reservoirs. The 
use of the microarray platform containing multiple AMR gene probes allowed the 
identification of important genes which would not have been feasible with PCR. In this 
case, it would have required prior knowledge of the gene likely present and testing of all 
isolates phenotypically resistant to the beta-lactams, which with these genera, would have 
been onerous.  
  
Conclusion 
Aeromonas and Vibrio are ubiquitous aquatic organisms, easily cultured, can cause 
diseases in humans and are known carriers of resistance genes. Preliminary identification of 
isolates to the genus level can be attained with a relatively high level of exactitude using a 
simple battery of tests and selective media. If definitive species identification is important, 
confirmation using one or a combination of biomolecular techniques is recommended. In 
the scope of a surveillance program, those isolates with phenotypic resistance patterns of 
concern and having the appropriate results for the five biochemical screening tests could 
then be speciated with genetic methods. 
The use of NRI to establish epidemiologic cut-off values was validated here by the 
presence of resistance genes and agreement between this method and the population 
distribution and gene presence was excellent. Minimal disagreement was evident between 
NRI-ECV’s, population distribution and/or gene presence for potentiated sulfa. This could 
likely be minimized for sulfamethoxazole-trimethoprim, by utilizing single antimicrobial 
agents for NRI calculation.  The identification of isolates with partial resistance to SXT 
(either trimethoprim or sulphonamide resistance), would help identify those where 
continual SXT therapy would more rapidly result in resistance selection. 
There was low occurrence (< 10%) of resistance to antimicrobials in both 
Aeromonas and Vibrio spp. isolated from fish and seafood, which seems to be in contrast 
with published literature concerning AMR in seafood and their aquaculture environment. In 
light of the low AMR prevalence and complexity of bacterial identification, periodic 
sampling and assessment of AMR in salmon and shrimps in rotation with other type of 
seafood, may be more appropriate and cost-effective than routine AMR surveillance of 
salmon and shrimp as is performed for other commodities in Canada.  Finally, the 
evaluation of resistant isolates for AMR genes using two techniques, simple PCR and 
microarray, permitted the corroboration of results in some cases and the identification of 
novel resistance determinants. 
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Annex 1: β-lactamase classification  
Amblera Bushb Enzyme type (s) Substate 
Inhibited 
by 
Representative enzymes 
A 2a Penicillinases penicillins CAc (Gram positive bacteria) 
A 2b 
Restricted-spectrum β-
lactamase 
penicillins and cephalosporins CA  
A 2be Extended spectrum β-lactamase 
penicillins, narrow and extended-
spectrum cephalosporins, monobactams 
CA TEM-3-26, SHV-2-6 
A 2br Inhibitor resistant β-lactamase penicillins - TEM-30-36, TRC-1 
A 2c Carbenicillinase penicillins, carbenicillin CA PSE-1, 2 & 3, CARB 
A 2e Cephalosporinase cephalosporins CA 
Inducible cesphalosporinases from 
Proteus vulgaris 
A 2f Carbapenemase 
penicillins, carbapenems, , 
cephalosporins, monobactams, sometimes 
extended-spectrum β-lactams 
±CA NMC-1, SME-1 
B 3 
Carbapenemase (metallo β-
lactamase) 
most β-lactams, carbapenems, and 
cephalosporins (4th gen.) 
EDTAd IMP-1-13, VIM-1-7, SPM-1 
C 1 Cephalosporinase 
penicillins, cephalosporins, cephamycins, 
and monobactams 
- AmpC, CMY, MIR, FOX 
D 2d 
Narrow spectrum penicillinase, 
ESBL, carbapenemase 
penicillins, cloxacillin, extended 
spectrum β-lactams , carbapenems , at 
times monbactams, and cephalosporins 
(4th gen.) 
CA OXA (many variants), PSE 
* 4 Penicillinase Penicillins - 
derived from Pseudomonas 
cepacia 
aAmbler β-lactamase classification adapted from Poole (2004) 
bBush-Jacoby-Medeiros β-lactamase classification adapted from Bush (1995) 
cClavulanic acid 
d Ethylenediamine-tetra-acetic acid 
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Annex 2: MIC’s of mobile β-lactamases reported in Aeromonas and 
Vibrio
a
  (in μg/ml) 
aMIC’s associated with Vibrio sp. are annotated in bold red. Numbers in [] correspond to reference  
Antimicrobials
a
 
PER-1 
[215] 
CTX-
M 
[142] 
PER-
2,TEM
-1 
[142] 
IMP-
19  
[152] 
VIM-4 
[216] 
TEM-
24 
[135] 
OXA-
1 
[137] 
OXA-
2 
[140] 
SAR-1 
[141] 
Carb-7 
[146] 
AmpC 
[149] 
Ampicillin - >1024 >1024 - >256 - - ≥50 >1000 256 1024 
Ampicillin/ 
sulbactam 
- - - - - - - - - 16 - 
Amoxicillin >256 - - - - >256 >32 - - - - 
Amoxicillin -
clavulanic acid 
8 4-8 16 - - 8 - - - - - 
Piperacillin - - - 256 - 32 - - - 32 256 
Piperacillin/tazo
bactam 
- 0.25 1 - >256 1 - - - - - 
Carbenicillin - - - - - - - - >1000 - 256 
Ticarcillin >256 128 128 2049 - >256 >256 - - 512 - 
Ticarcillin/CA 128 - - - - 32 - - - 8 - 
Oxacillin - - - - - - - - -  32 
Ceftiofur - - - - - - - - - - - 
Cephalothin >64 128-
512 
32 - - - - - - 2 - 
Cephaloridine - - - - - - - - - - 16 
Cephradine - - - - - - - - 16 - - 
Clavaluanic acid 
(CA)  
- - - 512 - - - - 16 - - 
Cefazoline - - - 512 - - - - - - - 
Cefpirome - - - - - 0.5 - - - - - 
Cefoxitin 2 4-8 4 1024 >256 16 - - - 8 - 
Tazobactam - - - 1024 -  - - - - - 
Ceftazidime 
(CAZ) 
>256 0.13-
0.25 
8 1024 >256 32 <0.06 - - - 2 
CAZ-CA - 0.13 0.13 - - 0.06 - - - - - 
Cefotaxime 
(CTX) 
>32 2-4 0.5 - >256 0.5 <0.06 - - - 2 
CTX-CA - <0.03 <0.03 - - - - - - - - 
Ceftriaxone - - - - >256 - - - - - - 
Cefepime (FEP) 4 2 1 - 32 0.25 <0.06 - - - - 
FEP-CA - <0.50 <0.50 - - ≤0.03 - - - - - 
Aztreonam - 8 128 8 - - - - - - - 
Imipenem 0.25 1 1 16 32 4 <0.06 - - - - 
Meropenem - - - 1 - - - - - - - 
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Annex 3: Tetracycline resistance genes identified in Aeromonas and 
Vibrio 
Genus Efflux proteins Ribosomal 
protection proteins 
Enzymatic 
proteins 
Aeromonas tet(A)(B)(C)(D)(E)(31)(Y) - tet(34) 
Vibrio tet(A)(B)(C)(D)(E)(G)(35) tet(M) tet(34) 
Adapted from Roberts [156] 
 
 
 
Annex 4: MIC’s associated with the tetracycline resistance genes of 
Aeromonas spp. and Vibrio
a
 spp. 
Resistance gene 
≤4 
μg/mL  
≤8 
μg/mL  
≤16 
μg/mL  
≤32 
μg/mL  
≤ or >64 
μg/mL  
≤128 
μg/mL  
≥256 
μg/mL  
tet(A) [185] 
[7, 185] 
 
[160] 
[164, 
185]  
[85, 161]  
[164, 
185] 
[159, 
185] 
[182] [91] 
tet(B)      
[166, 
182, 183] 
[184] 
[184] 
tet(C)    [177] 
[177] 
[159] 
  
tet(D)  [7]  [170]  
[165, 
166, 183] 
 
tet(E)  [7] 
[91, 160] 
[164] 
[161] 
[170] 
[164] 
[162] 
 [91] [91] 
tet(G     [184] [182] [184] 
tet(31/C)     [177]   
tet(34)       [174] 
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tet(35/tetA)      [172]  
tet(M)      [171] [171] 
tet(34/A)   [172] [172]  [172]  
tet(B,D,M); 
(A,D,M);(A,B,M)
(DEM) 
     
[165, 
217] 
[164] 
 
tet(A/B)      
[166, 
183] 
 
tet(A/C)     
[177] 
[159] 
[177]  
tet(A/B/D)      [166]  
tet(D/E)      [166]  
tet(A/E)  [7] [160] 
[161, 
164]  
[164] [166]  
tet(E/M)   [164]  [164]   
tet(A/M)   [164] [164]    
tet(D/M)  [164]    [164]  
tet(B/M)  [173] [173] [173] [173] [173] [173] 
tet(Y)   [179]     
aMIC’s associated with Vibrio sp. are annotated in bold red. . Numbers in [] correspond to reference 
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Annex 5: Aeromonas MIC’s for nalidixic acid, oxalinic acid and ciprofloxacin/enrofloxacin, and associated QRDR 
mutations 
Resistance 
determinant 
≤0.03 
μg/ml 
≤0.06 
μg/ml 
≤0.12 
g/ml 
≤0.25 
μg/ml 
≤0.5 
μg/ml 
≤1 
μg/ml 
≤2 
μg/ml 
≤4 
μg/ml 
≤8 
μg/ml 
≤16 
μg/ml 
≤32 
μg/ml 
64 
μg/ml 
128 
μg/ml 
≥256 
μg/ml 
Wild type 
strains 
[222] 
[62] 
[62] 
[228] 
 
[222] 
[222] 
[228] 
[224] 
[224] 
          
gyrA  
Se83Ile 
   
[222] 
[224] 
[225]  
[222] 
[222] 
[222] 
[225] 
[222] 
[222] 
[224]  
  
[222] 
[224] 
[222] 
[222, 
224] 
gyrA  
Se83Arg 
Se83Val 
  [222]  [222] [222]  [222]     [222] [224] 
gyrA 
Asp87Asn 
 
   [62] [62] [62] [62] [62] [62]      
gyrA 
Se83Ile, 
Ala67Gly 
Leu92Met 
    
[225] 
[224] 
[225] 
[224] 
 [225]       
gyrA/parC 
 
    
[228] 
[224] 
[222] 
 
[222] 
 
 
[222] 
[228] 
[222] 
[228] 
[224] 
 
[222, 
228] 
 
[222] 
[224] 
[222, 
224, 
228] 
[224] 
qnrS2     [137]  [137] [247]   [247]   [247] 
Note: MIC references for naladixic acid and ciprofloxacin/enrofloxacin are underscored in red and italic and black respectively.  MIC references for oxalinic acid are not 
underscored.  
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Annex 6: Vibrio MIC’s for nalidixic acid, oxalinic acid and ciprofloxacin/enrofloxacin and associated QRDR 
mutations 
 
Note: MIC references for naladixic acid and ciprofloxacin/enrofloxacin are underscored in red and italic and black respectively.  MIC references for oxalinic acid are not 
underscored.  
 
Resistance 
determinant 
≤ 0.03 
μg/ 
ml 
≤ 0.06 
μg/ml 
≤ 0.12 
g/ml 
≤ 0.25 
μg/ml 
≤ 0.5 
μg/ml 
≤ 1 
μg/ml 
≤ 2 
μg/ml 
≤ 4 
μg/ml 
≤ 8 
μg/ml 
≤ 16 
μg/ml 
≤ 32 
μg/ml 
≤ 64 
μg/ml 
≤ 128 
μg/ml 
≤ 256 
≥μg/ml 
Wild type 
strains 
[230, 
232] 
[233] 
[234] 
[232] 
[233] 
[233] 
[232] 
[232] 
[231, 
233] 
[232] 
[233] 
[231, 
234] 
[230, 
232] 
        
gyrA 
(Se83Ile) 
 [230]  [230] [230] [232] [232]  
[230, 
231, 
233, 
234]  
[232] 
[230, 
234] 
[232] 
[232, 
234] 
  
gyrA 
(Se83Arg) 
     [232] [232]     [232]   
gyrA 
(Asp87Ty
r) 
    [234]  [234] [234] [234]      
gyrA/gyrB      [232]  [232]     [232]  
gyrA/gyrB/p
arC 
     [232]    [232]    [232] 
gyrA/parC      
[230, 
232]  
[232]  
[232] 
[233, 
234] 
[230, 
233] 
[233]  
[231, 
232, 
234] 
[230-
232] 
[231, 
234] 
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Annexe 7: Identification Scheme for Aeromonas and Vibrio 
Presumptive 
identification 
(screening tests; Gram stain, triple 
sugar iron agar (TSI), oxidase, motiliy 
and 0129
Vitek2®
Confirmation by PCR Confirmation with 
biochemical tests
Selective media
(Aeromonas agar 
and TCBS)
28oC
18-24 hrs.
(rpoB) 
Sequencing BLAST
(« Basic local alignment search tool »)
Species = Maximum identity score of ≥99% 
Genus= Maximum identity score of ≥97%
<97% = failure of identification
Two isolates  conserved per sample
  
Daoust, P.Y., Health Canada, culture protocols  (non-published)  
 
 
Annexe 8: Sensitivity and specificity for Vitek2® identification of 
Aeromonas to the genus and species level using an rpoB gold standard 
 
 
rpoB 
Aeromonas + 
rpoB 
Aeromonas - 
Senstivity and 
specificity 
Kappa coefficient 
(Confidence 
intervals) 
Vitek2 - genus 
Aeromonas sp. + 
190 8 
Sensitivity (genus); 
96% 
0.38 
(0.176-0.600) Vitek2 - genus 
Aeromonas sp. - 
8 6 
Specificity (genus); 
43% 
Vitek2 - species 
Aeromonas sp. + 
22 23 
Sensitivity (species); 
12% -0.214 
(
-
0.268-0.148) Vitek2 - species 
Aeromonas sp. - 
156 11 
Specificity (species); 
32% 
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Annexe 9: Sensitivity and specificity for Vitek2
®
  identification of Vibrio 
to the genus and species level using an rpoB gold standard 
 
 
rpoB 
Vibrio + 
rpoB Vibrio 
- 
Senstivity and 
specificity 
Kappa 
coefficient 
(Confidence 
intervals) 
Vitek2 - 
genus 
Vibrio sp. + 
104 2 
Sensitivity (genus); 
60% 
0.056 
(
-
0.009-0.094) Vitek2 - 
genus 
Vibrio sp. - 
69 5 
Specificity (genus); 
71% 
Vitek2 - 
species 
Vibrio species 
+ 
42 2 
Sensitivity (species); 
24% 
-
0.004 
-
0.041-0.017) Vitek2 - 
species 
Vibrio species 
- 
131 5 
Specificity (species); 
71% 
 
 
Annex 10: Prevalence of resistance phenotypes in Aeromonas and Vibrio 
Resistance phenotype Aeromonas  (n=199) Vibrio (n=175) 
Fluoroquinolone 2.5% 0% 
Quinolone 3.5% 2.9% 
Florfenciol 0.5% 0% 
Sulfamethoxazole-
trimethoprim 
1.0% 4.6% 
Tetracycline 12% 5.7% 
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Annex 11: Differences in antimicrobial resistance gene detection noted 
between microarray and simple PCR 
Antimicrobial 
family 
AMR gene Aeromonas Vibrio 
  PCR Microarray PCR Microarray 
Folic acid 
inhibitors 
sul1 2
a
 0 -
b
 - 
 sul2 - - 6 0 
Phenicols floR 1 0 - - 
Tetracyclines tet(A) 3 3 0 2 
 tet(B) - - 4 2 
 tet(D) 0 1 - - 
 tet(E) 6 13 1 1 
Class 1 integron intI1 2 0 0 0 
a
Numbers of isolates containing indicated resistance gene 
b
Hypens indicate comparisons were not possible 
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Annex 12: Antimicrobial resistance genes identified by microarray 
Antimicrobial 
family 
AMR genes Aeromonas (n=18) Vibrio (n=12) 
Aminoglycosides strA/strB 2
 a
 2
 a
 
 aadA1 1 0 
β-lactams blaVIM2 3 1 
 blaFOX2 21 0 
 blaSME 3 1 
 blaTEM 5 0 
Inhibitors of folic 
acid 
dhfr5 3 1 
 dhfr7 0 3 
 dhfr16 1 0 
Macrolides ereB 0 4 
 ereA2 2 0 
Phenicols cat 2 1 
 cat2 1 0 
 cat3 2 1 
Tetracyclines tet(A) 3 2 
 tet(B) 0 2 
 tet(D) 1 0 
 tet(E) 13 1 
a
Numbers of isolates containing indicated resistance gene 
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Abstract 
Antimicrobial use in the aquaculture setting is generally considered low as compared to 
other types of animal production, however, where endemic disease requires frequent 
therapeutic intervention, or in countries where antimicrobial usage is poorly regulated, the 
quantities used may be considerably higher. This may lead to increased occurrence of 
antimicrobial resistance (AMR) in aquaculture products and increased human exposure.  
Little information is available concerning the occurrence of antimicrobial resistance in 
finfish and seafood available at the retail level in Canada.  In this study, 216 Aeromonas 
isolates were cultured from 281 finfish and shrimp sampled within the framework of the 
Canadian Integrated Program for Antimicrobial Resistance Surveillance. Bacteria were 
identified using Vitek2
®
 and confirmed by sequencing of the rpoB gene. Epidemiological 
cut-off values were estimated for the tetracyclines (TET), folic acid inhibitors (SXT), 
quinolones (ENO and NA) and florfenicol (FFC) using Normalised resistance interpretation 
of the disk diffusion data. Gene presence associated with resistance phenotypes was 
evaluated using PCR and microarray analysis. Aeromonas prevalence in finfish and shrimp 
was 58% and 22% respectively, where the Aeromonas enchelaie/A. salmonicida was the 
species most often identified. The prevalence of Non-Wild-Type (NWT) 
phenotypes/sample of the antimicrobials examined was:  0.5%, 2.5%, 3.5%, 1.0% and 12% 
for FFC, ENO, NA, SXT and TET respectively.   The gene tet(E) (74%) and tet(A) (21%) 
were the only tet resistance determinants identified in TET-NWT isolates. In two SXT-
NWT isolates sul1 was found in combination with either dfrA5 or dfrA5/dfrA16. Among six 
of seven isolates demonstrating a NWT phenotype for quinolones, single or dual mutations 
in gyrA were found (gyrASe83-Ile, gyrASe83-Ile/gyrAMet92-Leu. gyrASe83-Val) and in certain cases 
in combination with substitutions in parC (parCSe80-Ile parCAla85-Thr, parCPro98-Ser). The floR 
gene was found in the single FFC-NWT isolate. Plasmid profiling and hybridization 
revealed that the resistance determinants tet, sul1, floR and intI1, were on plasmids ranging 
in size from 9.5 kb to 20 kb. Overall prevalence of AMR in seafood identified in this study 
was low and the majority of the AMR phenotypes could be explained by the presence of 
resistance determinants or gene mutations.  
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1.0 Introduction 
Aquaculture is the fastest growing agri-industry in the world.  It currently accounts for 46% 
of the world fish supply and is poised to overtake wild fisheries as the primary fish source 
(FAO, 2010). Antimicrobial exposure in the aquaculture setting is generally considered low 
as compared to other types of animal production, however, in countries where endemic 
disease requires frequent therapeutic intervention, or in countries where antimicrobial usage 
is poorly regulated, the quantities used may be considerably higher (FAO/OIE/WHO, 
2006).  The majority of antimicrobial therapy in aquatic production is administered orally, 
therefore, in addition to antimicrobial exposure of the bacterial population causing disease, 
the bacterial flora on fish and in the surrounding environment are also exposed.  
 
Antimicrobial resistance (AMR) has been reported in many species of aquatic bacteria in 
freshwater and marine environments (Akinbowale et al., 2006; Biyela et al., 2004; Goni-
Urriza et al., 2000).  Aeromonas species are gram-negative, mobile, facultative anaerobic 
bacteria that are present in aquatic systems worldwide and are frequently found in fish, 
shellfish and other seafoods (Davies et al., 2001; Hanninen et al., 1997). They are important 
bacterial pathogens of cultured fish and certain Aeromonas species are recognized as 
zoonotic pathogens.  Food poisoning and gastroenteric infections are the most commonly 
encountered disease in humans and are treated symptomatically, whereas severe systemic 
infections may require the administration of antimicrobials (Daskalov, 2006; Hsiao et al., 
2008).  In these cases, AMR could limit the success of antimicrobial therapy.  Additionally, 
multiple laboratory studies have demonstrated that resistant determinants can be transferred 
between aquatic bacteria which are low pathogen risks to humans such as Aeromonas 
salmonicida, to more pathogenic Enterobacteriaceae (Kruse and Sorum, 1994; Schmidt et 
al., 2001; Sorum et al., 2003). If this exchange occurs, at what frequency and how it 
happens in the environment or in association with seafood has yet to be elucidated.  Recent 
studies examing Aeromonas in retail seafood have shown elevated levels of AMR but have 
not examined the genetic basis for these phenotypes (Castro-Escarpulli et al., 2003; 
Kaskhedikar and Chhabra, 2010; Radu et al., 2003; Vivekanandhan et al., 2002).  This 
study examines the antimicrobial resistance phenotypes of Aeromonas sp. isolated from 
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retail seafood in Canada, as well as their associated genetic determinants using MIC, disk 
diffusion, PCR and microarray techniques. 
 
2.0  Materials and Methods 
2.1 Sample collection and bacterial isolation 
Two hundred and eighty one retail seafood samples (143 salmon, 128 shrimp, 6 trout and 4 
tilapia) were obtained between the 20
th
 of October, 2008 and the 15
th
 of June 2009, within 
the sampling framework of the Canadian Integrated Program for Antimicrobial Resistance 
Surveillance (CIPARS).  They originated from five different Canadian regions including 
Québec, Ontario, the Maritimes, Saskatchewan, and British Columbia. Finfish samples 
taken included filets or steaks (skin-on or skin-off) whereas shrimp samples were submitted 
whole and the preservation of samples varied from fresh or thawed to frozen. 
Approximately 100 grams of each sample was placed individually in 7x12inch sterile 
“Stomacher” bags (VWR International, Mississauga, ON) with 225ml of alkaline peptone 
water (APW) and homogenized by hand for two minutes with subsequent incubation at 
28
o
C for 18-24 hours. Aeromonas species were cultivated and selected by inoculating an 
Aeromonas-selective AA agar plate (Aeromonas medium base (Ryan) with ampicillin 
supplement, Oxoid, Cambridge, UK) with a loopful of the APW enrichment.  Four green 
colonies with darker centers were selected and subcultured on tryptic soy agar (TSA)-Blood 
+ 5% sheep blood for further testing.  
 
2.2 Bacterial identification 
Putative Aeromonas isolates were subjected to an initial panel of tests including: Gram 
stain, motility, oxidase, triple sugar iron (TSI) agar and 0129 susceptibility (2,4-diamino. 
6,7-diisopropylpteridine phosphate, 150mg) (BD-BBL, Mississauga, Ontario).  A putative 
Aeromonas sp. identification was given to those isolates found to be Gram-negative, motile, 
oxidase positive, resistant to 0129 and demonstrated an acid/acid or alkaline/acid reaction 
with the presence of gas and absence of H2S on TSI slant. Two (commenataire PF : 
comment passe-t- on de 4 colonies à 2 isolats , critères de sélection?) isolates per positive 
sample were conserved when available in tryptic soy broth (TSB) + 50% glycerol at -80
o
C 
for further testing. 
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Two hundred and sixteen putative Aeromonas sp. isolates were then identified using the 
Vitek2
®
 identification system following protocols outlined by the company. This 
identification was confirmed via amplification of the ribosomal polymerase subunit rpoB as 
previously described with some modifications (Kupfer et al., 2006).  PCR amplification 
was performed in 25 μl
 
containing; 2 μl 10X PCR buffer, 0.08 mM dNTPs, 0.2 mM MgCl2, 
10 pmol of opposing primers,  1.25U Taq polymerase (New England Biolabs, Pickering, 
Ontario) and from 50-100 ng of DNA template.  A temperature of 56
o
C was used during 
the hybridization step.  Amplicons were evaluated by visualization following migration of 
an agarose gel (1.7%) stained with ethidium bromide. An E-gel low range semi-quantitative 
ladder (Invitrogen Canada, Burlington, Ontario) was used as a comparative marker for 
product sizing, and A. salmonicida ATCC33658, Aeromonas hydrophila ATCC7966 and 
Aeromonas caviae ATCC15468 were used as controls. The same primers were used for 
subsequent sequencing reactions of the approximately 540 bp PCR product. Sequencing 
was performed by the Plate-forme d'analyses biomoléculaires (PAB), Université Laval. 
Identification was made using the National Center for Biotechnology Information (NCBI) 
basic local alignment search tool (BLAST) (Altschul et al., 1990).  Identification to the 
species level was defined as an rpoB sequence ‘Maximum identity score’ of ≥ 99% with 
that of strain sequences in GenBank whereas identification to the genus level was defined 
as those isolates having a ‘Maximum identity score’ of  ≥ 97%.  A score of lower than 97% 
was considered as a failure of identification (Drancourt et al., 2000). 
 
2.3 Antimicrobial susceptibility testing 
All 216 isolates were tested for antimicrobial susceptibility by broth microdilution (MIC) 
and by disc diffusion using methods for aquatic organisms published by CLSI (M42-A, 
M49-A). For MIC determination, the ARIS automated system of Sensititre
TM
 (Trek
TM
 
Diagnostic System Ltd) with a custom aquatic plate was used, containing (MIC range in  
µg/ml in parenthesis): enrofloxacin (0.002-1), florfenicol (0.03-16), oxalinic acid (0.004-2), 
oxytetracycline (0.015-8) and sulfamethoxazole/trimethoprim (0.015/0.3-1/19).  
Antimicrobials evaluated by disk diffusion included (antimicrobial disc concentration in µg 
in parenthesis): enrofloxacin (5), florfenicol (30), nalidixic acid (30), 
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sulfamethoxazole/trimethoprim (23.75/1.25) and tetracycline (30) (BD-BBL, Mississauga, 
Ontario).  Incubation temperature for all testing was 28
o
C.  Quality control for both testing 
methods was performed using Escherichia coli ATCC 25922 and A. salmonicida ATCC 
33658.  The calculation of the Epidemiological Cut-Off Value (ECV) for the interpretation 
of susceptibility of isolates was accomplished using NRI of disk diffusion data as 
previously described (Kronvall, 2003; Kronvall et al., 2003).  For the NRI calculations, 
peak values were established using four point rolling means, and a plot of seven probit 
values versus zone size was used to identify the means and standard distribution of the 
susceptible population.  ECV’s were set at 2.5 standard deviations from the mean.  Non-
susceptible isolates are considered as Non-Wild-Type (NWT) and susceptible isolates, 
Wild-Type (WT). 
 
2.4 ERIC-PCR 
All isolate pairs derived from one sample which demonstrated identical AMR patterns were 
evaluated for clonality using an ERIC-PCR with conditions as previously described 
(Novakova et al., 2009) with minor modifications. The amplification reaction was carried 
out in 25 µl containing: 2 µl of 10X PCR Buffer, 0.064mM dNTPs, 0.16mM MgCl 2, 50 
pmol of opposing primers, 2 U of Taq DNA polymerase (NewEngland Biolabs, Pickering, 
Ontario) and 100-200 ng of template DNA. Ten µl of PCR product was subsequently 
evaluated by electrophoresis in a 1.5 % agarose gel for 120 min (7.3 V/cm) in TAE buffer 
(Tris base, acetic acid and EDTA).  Gels were stained with ethidium bromide (1.0 mg/L) 
for 20 min, destained in deionized water for 20 min, and visualized under UV light. Image 
analysis of the obtained patterns was carried out using BioNumerics Version 6.0.1 software 
(Applied Maths, Austin, TX, USA). A clustering analysis was performed using the 
unweighted pair group method using arithmetic averages (UPGMA) based on the Pearson’s 
correlation coefficient. An optimisation of 1% was allowed, and a threshold of 95% was 
used to identify bacterial clones.(attention asvez vous une référence qui justifie 95% 
comme seuil de clonalité) 
 
2.5 Detection of antimicrobial resistance genes 
PCR was used to detect individual AMR determinants including tet((A), (B), (C), (D) and 
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(E)), florR, sul1and sul2.  A PCR followed by sequencing was used to detect gyrA/parC 
mutations and the primers used are presented in Table 1. Identical amplification reactions 
were used for floR, sul1 and sul2 with  2.0 µl of 10X PCR Buffer, 0.08 mM dNTPs, 0.25 
mM MgCl2, 10 pmol of opposing primers, 1 U of Taq DNA polymerase (NEB) and 50-100 
ng of template DNA in a total volume of 20 µl.  Briefly, the PCR reactions used were: floR: 
initial denaturation (94°C, 5 min), 35 polymerization cycles (94°C for 30 s, 60°C for 30 s 
and 72
o
C for 30 s), final elongation at 72°C for 7 min; sul1: initial denaturation (95°C, 5 
min), 25 polymerization cycles (95°C for 30 s, 55°C for 30 s and 72
o
C for 40 s) final 
elongation at 72°C for 7 min;  sul2: initial denaturation (95°C, 5 min), 35 polymerization 
cycles (95°C for 30 s, 62°C for 30 s and 72
o
C for 45 s) and final elongation at 72°C for 7 
min. All tet genes ((A), (B), (C), (D) and (E)) were amplified using identical amplification 
reactions and PCR conditions.  The PCRs consisted of 2.0 µl of 10X PCR Buffer, 0.08 mM 
dNTPs, 0.14 mM MgCl2 10 pmol of opposing primers, 1 U of Taq DNA polymerase (NEB) 
and 50-100 ng of template DNA, in a total volume of 20 µl.  The PCR conditions included 
an initial denaturation step (95°C, 5 min), followed by 35 polymerization cycles (95°C for 
30 s, 62°C for 30 s and 72
o
C for 45 s) and final elongation at 72°C for 7 min. Amplification 
of qnrA, qnrB and qnrS genes was undertaken utilizing a multiplex PCR as previously 
described (Gay et al., 2006).  The gyrA and parC genes were amplified using conditions 
described previously using the gyrm1-2, parm1-2 primer pairs (Okuda et al., 1999).  The 
same primers were used for subsequent sequencing reactions of the approximately 500  bp 
PCR product. Comparison to phenotypically susceptible isolates of the same genera was 
performed to characterize mutations in the quinolone resistance determining region 
(QRDR). Nineteen non-wild type isolates, were further examined for the presence of 
resistance genes using a microarray previously described by Bonnet (2009) (Bonnet et al., 
2009). 
 
2.6 Plasmid extraction and hybridization 
Plasmid extraction was performed in selected isolates with confirmed AMR genes using the 
Plasmid Midi kit (Qiagen, Ontario, Canada) according to the manufacturer’s specifications.  
Subsequently, plasmid extracts were subjected to electrophoresis in 0.7% agarose gel at 
7.3 V/cm for 180 minutes followed by staining with  ethidium bromide . The supercoiled 
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DNA ladder (Invitrogen Canada, Burlington, Ontario) and BacTracker BAC-Tracker™ 
Supercoiled DNA Ladder (Epicentre Biotechnologies, Madison, Wisconsin, USA) were 
used as molecular weight markers. Probes for Southern blot hybridization were generated 
for tet(A), tet(E), tet(B),  floR, sul1, sul2 and intI1 using the PCR DIG probe synthesis kit 
(Roche-Scientific, Canada) according to the manufacturer’s instructions.  DNA from 
plasmid extractions was transferred to positively charged nylon membranes using a 
Vacuum Blotter Model 785 (Bio-Rad, Mississauga, Ontario, Canada) and revealed with the 
DIG Nucleic Acid Detection Kit (Roche-Scientific, Canada) as per manufacturer’s 
instructions. 
 
2.6 Statistics 
Identification test performance (Kappa, sensitivity and specificity) was evaluated using the 
2-way contingency analysis tool found at http://statpages.org.   
 
3.0 Results 
3.1 Bacterial isolation 
Of the 281 seafood samples examined, 216 putative Aeromonas species were isolated from 
174 (80.5%) and 42 (19.5%) of the finfish and shrimp samples respectively. Prevalence of 
Aeromonas in seafood based on the rpoB identification described below was 58% for 
finfish and 22% for shrimp. Comment expliquer une prévalence > après rpoB identification 
qui est présentée dans le matériel et méthode comme intervenant après VITEK2… modifier 
le M &M? 
 
3.2 Bacterial identification  
Among 216 presumptive Aeromonas spp. isolates, 199 were identified as Aeromonas sp. 
using the Vitek2
®
 system. Among these, 142 (66.7%) were identified as A. 
hydrophila/caviae, 57 (26.7%) as A. sobria, 6 (2.8%) as Vibrio sp. and 8 (3.8%) as other 
species. Confirmation by sequencing of the rpoB gene identified 199 isolates as 
Aeromonas, and revealed a larger number of species including: A. enchelaie/A. 
salmonicida, 65 (30.2%);  A. sobria, 28 (13.0%);  Aeromonas spp., 30 (14.0%);  A. 
bestiarum, 20 (9.3%);  A. molluscorum, 18 (8.4%);  A. encheleia, 17 (7.9%);  A. 
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salmonicida, 12 (5.6%);  A. veronii, 6 (2.8%);  A. enteropelogenes, 2 (0.9%);  A. punctata, 
2 (0.9%);  A. media, 1 (0.5%).  Species other than Aeromonas accounted for 6.5% of the 
above population ou other species in aeromonas genus? Avez vous fait rpoB sur les 17 
souches non Aeromonas par Vitek2?.  Agreement Attention on ne peut calculer le Kappa 
que si il y a independance des jugements ce qui n'est pas le cas si on suit le M&M of 
identification of isolates between Vitek2
®
 and rpoB was poor. Kappa coefficient values for 
agreement at the genus and species level as well as sensitivity and specificity using rpoB as 
the identification gold standard are shown in Table II.  
 
3.3 Antimicrobial susceptibility testing  
The distribution of inhibition zone diameters and MIC’s for 199 rpoB confirmed 
Aeromonas sp. are presented in Figure 1. NWT isolates were identified in 21 samples 
examined. NWT phenotypes for more than one antimicrobial was noted in five isolates and 
included : TET/NA (n=4) and TET/SXT/FFC (n=1) phenotypes. TET was the most 
prevalent single NWT phenotype (n=15) followed by NA (n=3) and SXT (n=1).  
Prevalence of NWT phenotypes/sample of the antimicrobials examined was :  0.5%, 2.5%, 
3.5%, 1.0% and 12% for FFC, ENO, NA, SXT and TET respectively.  
 
3.4 Evaluation of clonality with ERIC-PCR  
Non-susceptible Aeromonas isolates were identified in 21 fish/seafood samples and in six 
of the samples, the two isolates retained demonstrated the same NWT phenotype.  
According to rep-PCR analysis, the isolate pairs from four of these were culture replicates.   
 
3.5 Detection of antimicrobial resistance genes  
All NWT isolates were examined for the presence of resistance genes using PCR, and 19 
isolates were further characterized using the microarray and to examine NWT phenotypes 
for which no resistance genes were identified.  Genes detected by PCR and microarray are 
listed and contrasted in Tables III and IV. Genes coding for tetracycline NWT were 
detected by both PCR and microarray. The gene tet(E) was the most prevalent at 73.7%  
followed tet(A) at 21.1%.  In two isolates, no AMR supporting genes were detected. The 
two NWT isolates identified for folic acid inhibitors were associated with the presence of 
xxxii 
 
 
sul1 and either dfrA5 or dfrA5/dfrA16. All but one of seven isolates demonstrating a NWT 
phenotype for quinolones were found to contain single or dual mutations in gyrA (gyrASe83-
Ile, gyrASe83-Ile/gyrAMet92-Leu, gyrASe83-Val).  Certain isolates also harboured parC substitutions 
including parCSe80-Ile parCAla85-Thr, and parCPro98-Ser. The floR gene was detected in the 
single isolate demonstrating a NWT phenotype for florfenicol.  The relationship of AMR 
phenotypes and genotypes are detailed in Table V. 
 
3.6 Plasmid identification and gene carriage 
The majority of the isolates examined contained multiple plasmids ranging from 2.5 to 30 
kb in size. One isolate harboured a single plasmid of 9.5 kb. Those associated with the 
resistance determinants tet, sul1, floR and intI1, ranged in size from 9.5 – 20 kb (Table V).   
 
4.0 Discussion and Conclusion 
Aeromonas species were detected in 58% of the finfish and 16% On parle de 22% plus haut 
(abstratc et resultats) of the shrimp sampled in this study which is comparable to ranges 
published in the literature(Castro-Escarpulli et al., 2003; Radu et al., 2003; Vivekanandhan 
et al., 2002; Yucel and Balci, 2010). Bacterial identification in this study was based on 
biochemical screening followed by confirmation using a commercial biochemical panel 
(Vitek2
®
) and sequencing of the rpoB gene. Various authors have demonstrated difficulties 
of Aeromonas identification using biochemical methods and this appeared to be in 
agreement with the results of this study (Carson et al., 2001; Ormen et al., 2005). The 
Kappa coefficients for agreement between rpoB and Vitek2
®
 were low at the genus and 
species level, 0.38 and -0.214 respectively même remarque sur la nécessaire indépendance 
préalable, and indicate slight or no agreement between the two.  If rpoB sequencing were to 
be considered as the gold standard for identification, the Vitek2
®
 performs better at the 
genus level, with a sensitivity (Se) of 96% and specificity (Sp) of 43%, whereas the Se/Sp 
for speciation is only 12%/32%.  In the latter case, a large percentage of Aeromonas species 
would be wrongly identified. 
 
When investigating AMR, the conservation of more than one isolate may be advantageous 
as it can increase sampling sensitivity in a situation where prevalence is low (commentaire 
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P Boerlin : à expliquer ou préciser). A duplication of AMR phenotypes in Aeromonas 
isolated from the same sample were investigated in six of 24 samples using the rep-PCR 
methods described by Novakova (2009).  According to rep-PCR anlaysis, the isolate pairs 
from four of these were clonal.  In consideration the data here, if only one isolate was 
selected for identification and AMR determination and in 50 percent of the cases (a coin 
toss) it was the sensitive isolate, the overall apparent prevalence of samples exhibiting some 
type of AMR would drop from 17% to 14%. This decrease must be considered when 
planning the sampling and isolation protocols with respect to the surveillance goals.  
 
In this study, the level of NWT isolates is low for all antimicrobials studied ranging from 
0.5% for FFC to 12% for TET.  Higher levels of AMR are reported in the literature for 
Aeromonas isolated from retail seafood with ranges for: fluoroquinlones (10-42%), NA(17-
58%), SXT(38-49%) and TET(44-51%) reported (Castro-Escarpulli et al., 2003; 
Kaskhedikar and Chhabra, 2010; Radu et al., 2003; Vivekanandhan et al., 2002).  
Differences in sampling and testing methods, bacterial identification, market types, 
regions/countries and seafood species sampled, among other variables, likely contribute to 
this disparity. 
 
Commentaire P Boerlin : il serait judicieux de faire une comparaison de correlation 
genotype/phenotype versus microarray seule /versus PCR seule. Both PCR and microarray 
techniques were utilised to verify the presence of AMR genes and differences in detection 
were noted between the two techniques. Only 6 of the 13 tet(E) determinants identified by 
microarray were found by PCR, and conversely, sul1, floR and intI1 were only identified by 
PCR and not by the microarray. Variations in the genes that were used to design primers 
and probes may be important enough between bacterial genera to explain these differences, 
as the microarray used here was validated for E. coli. When considering the tet genes, the 
use of the microarray was an important complementary tool for identifying resistant 
determinants responsible for the expressed phenotypes. 
 
The presence of tetracycline as the most frequently identified NWT phenotype is not 
surprising as tetracycline were among the earliest antimicrobials available for use in 
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aquaculture and according to a recent survey of aquaculture-allied professional (Tusevlak et 
al, in prep), tetracycline is the most frequently used antimicrobial world-wide, all species 
confounded (Tuševljak, In-preparation). The genes tet(A) and tet(E) were the only 
determinants identified here and their presence is frequently reported in Aeromonas 
(Agerso et al., 2007; Balassiano et al., 2007; DePaola et al., 1988).  All but two of the TET-
NWT isolates were correlated to gene presence. The presence of phenotypic TET resistance 
in the absence of the responsible gene is commonly reported, and may likely suggest the 
presence of a new or variant tetracycline resistance determinant not present in other species,  
(Balassiano et al., 2007; Furushita et al., 2003; Schmidt et al., 2001).  
 
Mutations of the gyrA and parC gene are the most commonly reported cause of decreased 
susceptibility to quinolones in Aeromonas (Alcaide et al., 2010; Goni-Urriza et al., 2002).  
Substitutions at the 83
rd
 and 92
nd
 codon of gyrA and at the 80
th
 codon of parC are frequent, 
and were identified in non-susceptible isolates.  In one isolate additional substitutions were 
noted in parC at codons 85 and 98.  Although multiple mutations in gyrA and parC have 
been cited as being responsible for increased fluoroquinolone resistance, this did not seem 
to be the case here as all isolates with NWT phenotypes had MIC’s ranging from 0.25 to 
1µg/ml.  
 
NWT phenotypes for FFC and SXT were found the least frequently.  The only two SXT-
NWT isolates found were associated with sul1, dfrA5 or dfrA5/dfrA16 and in both cases 
were identified in association with the intI1 gene indicating the presence of a Class 1 
integron.  Although the intI1 gene was found in five other isolates, it was not found with 
sul1 or resistance cassettes which has also been reported by others (Jacobs and Chenia, 
2007; Rosser and Young, 1999).  The single isolate with a FFC-NWT phenotype contained 
the floR gene.  Additional chloramphenicol resistance genes were identified by the 
microarray, including cat, cat2 and cat3. These genes encode for resistance to 
chloramphenicol through chemical disactivation, but have no effect on florfenicol.  If the 
prevalence of this gene/resistance phenotype is important chloramphenicol should be 
included in the AMR panel to better target resistant isolates. 
 
xxxv 
 
 
Several β-lactamase genes were identified by microarray including blaVIM2, blaFOX2, blaSME, 
and blaTEM.  The presence of transferable β-lactamase genes is difficult to detect in 
Aeromonads which are intrinsically resistant and normally demonstrate a resistant 
phenotype to β-lactams.  In this study for example, all but one isolate was resistant to 
ampicillin.  Therefore, the acquisition and preservation of these genes does not seem to be 
dependent on selection of resistant bacterial populations through β-lactam exposure.  
Aeromonas can harbour these genes on mobile genetic elements as in other genera, and 
therefore, could be considered as a reservoir. 
 
The plasmids identified in this study were of low molecular weight, and have a similar size 
range as that previously reported (Radu et al., 2003).  Those described by Sorum (2003), 
associated with resistance determinants in environmental or clinical isolates are generally 
larger, than what was found here, even up to 150 kb (Sorum, 2006). Larger plasmids can be 
more difficult to isolate due to shearing during the extraction process, however, as the 
majority of the resistance genes were localised on low-molecular weight plasmids in this 
study, even if present (6/19) their importance remains unclair as some tet determinants were 
not localised to a specific plasmid.  This could indicate a chromosomal location, or perhaps 
low copy-number and/or larger plasmids.  
Overall prevalence of AMR in seafood identified in this study was low and the majority of 
the AMR phenotypes were explained via gene identification.  Although microarray analysis 
was unable to identify certain genes identified by PCR, it was useful as a complementary 
tool when investigating AMR phenotypes unobserved by PCR.  Identification of 
Aeromonad species using biochemical means appeared to be unreliable, and if bacterial 
speciation is important, a genetic component should be included in the identification 
scheme.   
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Table S1: AMR probes present on the microarray and reference genes, used in this study. 
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Figure 1: Histogram of inhibition zone diameters of the Aeromonas sp. 
population 
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Note: The calculated NRI-ECV value for each antimicrobial is indicated by the 
vertical dotted black line. 
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Table I: Primers used for PCR analysis of resistance genes 
Gene Primer Nucleotide Sequence 5’-3’ Product 
size (bp) 
Reference 
florR floR-F 
floR-R 
GAGATCGGATTCAGCTTTGC 
TCGGTAGGATGAAGGTGAGG 
198 This study 
gyrA gyrA-F 
gyrA-R 
TCCTATCTTGATTACGCCATG 
CATGCCATACCTACCGCGAT 
481 (Goni-Urriza et al., 
2002) 
intI1 IntI1-F 
IntI1-R 
GGGTCAAGGATCTGGATTTCG 
ACATGGGTGTAAATCATCGTC 
483 (Mazel et al., 2000) 
parC parC-F 
parC-R 
GTTCAGCGCCGCATCATCTAC 
TTCGGTGTAACGCATTGCCGC 
225 (Goni-Urriza et al., 
2002) 
qnrA QnrA-F 
QnrA-R 
ATTTCTCACGCCAGGATTTG 
GATCGGCAAAGGTTAGGTCA 
516 (Gay et al., 2006) 
qnrB QnrB-F 
QnrB-R 
GATCGTGAAAGCCAGAAAGG  
ACGATGCCTGGTAGTTGTCC 
469 (Gay et al., 2006) 
qnrS QnrS-F 
QnrS-R 
ACGACATTCGTCAACTGCAA 
TAAATTGGCACCCTGTAGGC 
417 (Gay et al., 2006) 
sul1 sul1-F 
sul1-R 
CTTCGATGAGAGCCGGCGGC 
GCAAGGCGGAAACCCGCGCC 
 (Falbo et al., 1999) 
tet(A) Tet(A)-F 
tet(A)-R 
GTAATTCTGAGCCACTGTCGC 
CTGCCTGGACAACATTGCTT 
 (Schmidt et al., 2001) 
tet(B) tet(B)-F 
tet(B)-R 
CTCAGTATTCCAAGCCTTTG 
CTAAGCACTTGTCTCCTGTT 
 (Schmidt et al., 2001) 
tet(C) Tet(C)-F 
tet(C)-R 
TCTAACAATGCGCTCATCGT 
TCTAACAATGCGCTCATCGT 
 (Schmidt et al., 2001) 
tet(D) tet(D)-F 
tet(D)-R 
TTGCGGCTTCGGTAGTGGCG 
CATGCATCGCCCCGAGTCCC 
  
tet(E) tet(E)-F 
tet(E)-R 
GTGATGATGGCACTGGTCAT 
CTCTGCTGTACATCGCTCTT 
 (Schmidt et al., 2001) 
Class 1 
integron 
variable 
region 
IC1-F 
IC1-R 
TTATGGAGCAGCAACGATGT 
CTGTGAGCAATTATGTGCT 
variable (Chang et al., 2007) 
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Table II: Sensitivity and specificity for Vitek2® identification of 
Aeromonas to the genus and species level using an rpoB gold standard 
 
rpoB 
Aeromonas 
pos. 
rpoB 
Aeromonas 
neg. 
Senstivity or 
Specificity 
Kappa 
coefficient 
(Confidence 
intervals) 
Vitek2 - genus 
Aeromonas sp. 
pos. 
190 8 
Sensitivity 
(genus); 96% 
0.38 
(0.176-0.600) Vitek2 - genus 
Aeromonas sp. 
neg. 
8 6 
Specificity 
(genus); 43% 
Vitek2  
species 
Aeromonas sp. 
pos. 
22 23 
Sensitivity 
(species); 
12% 
-0.214 
(
-
0.268-0.148) Vitek2  
species 
Aeromonas sp. 
neg. 
156 11 
Specificity 
(species); 32% 
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Table III: Differences in antimicrobial resistance gene detection noted 
between microarray and PCR(proposition de P Boerlin élimination des 
résultats Vibrio) 
Antimicrobial 
/integron family 
AMR gene Aeromonas  
  PCR Microarray   
Folic acid 
inhibitors 
sul1 2
a
 0   
 sul2 - -   
Phenicols floR 1 0   
Tetracyclines tet(A) 3 3   
 tet(B) - -   
 tet(D) 0 1   
 tet(E) 6 13   
Class 1 integron intI1 2 0   
a
Numbers of isolates containing indicated resistance gene 
b
Hypens indicate comparisons were not possible 
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Table IV: Antimicrobial resistance genes identified by microarray in 
Aeromonas 
Antimicobial family Genes Isolates (n=18) 
Aminoglycosides strA/strB 2
a
 
 aadA1 1 
β-lactams blaVIM2 3 
 blaFOX2 1 
 blaSME 3 
 blaTEM 5 
Inhibitors of folic 
acid 
dhfr5 3 
 dhfr16 1 
Macrolides ereA2 2 
Phenicols cat 2 
 cat2 1 
 cat3 2 
Tetracyclines tet(A) 3 
 tet(D) 1 
 tet(E) 13 
a
Numbers of isolates containing indicated resistance gene 
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TableV: Isolates with resistance phenotypes of four antimicrobial families and associated resistance genes 
Isolate 
No. 
Identificationa 
Sample 
type/origin 
Resistance 
phenotype 
Resistance genes detected by 
PCR or microarray 
intI1 Associated plasmid 
6A1 A.  sobria Trout TET tet(E) - - 
12A2 A. veronii Trout 
TET, SXT, 
FFC 
tet(A), sul1, floR, dfrA16,dfrA5 + (dfr16) ~12kbp 
13A1 A. encheleia Salmon TET, NA tet(E), gyrA Se83-Val - ~12kbp 
35A2 
A. veronii or  
A. sobria 
Salmon TET tet(A) - - 
36A2 A. sobria Trout TET tet(A) - - 
92A1 A. enteropelogenes Shrimp NA, ENO gyrASe83-Ile, parCSe80-Ile  - - 
98A1 A. encheleia Salmon TET tet(E) - - 
133A2 A. sobria Salmon TET, NA 
tet(E), gyrASe83-Ile parCAla85-Thr, 
and parCPro98-Ser 
- - 
140A1 A. encheleia Salmon TET tet(E) - ~12kbp 
155A1 A. sobria Salmon TET tet(E) - - 
167A2 
A. encheleia or  
A. salmonicida 
Salmon TET tet(E) - - 
209A2 
A. encheleia or  
A. salmonicida 
Shrimp 
TET, NA, 
 ENO 
 gyrASe83-Ile, Leu92-Met, tet(E) - ~12kbp 
227A1 A. veronii or A.sobria Salmon SXT sul1, dhfr5 + (aadA1) ~20kbp 
234A2 
A. encheleia or  
A. salmonicida 
Salmon TET tet(E) - - 
242A2 A. sobria Salmon TET tet(E) - - 
252A2 
A.encheleia or 
 A.salmonicida 
Salmon TET tet(E) + (no cassette) ~18kbp 
255A2 
A.encheleia or 
 A.salmonicida 
Salmon TET tet(E) - - 
259A2 A. veronii Salmon TET tet(E) - - 
276A1 
A. encheleia or  
A. salmonicida 
Salmon NA, ENO tet(E), gyrA Se83-Val - - 
aIsolates were identified by sequencing of rpoB and comparison with the Genbank database 
bAbbreviations for the antimicrobials used:   florfenicol (FFC), tetracycline (TET) and trimethoprim-sulfamethoxazole (SXT),  
naladixic acid (NA), enrofloxacin (ENO) 
 
xliii 
 
 
References 
Agerso, Y., Bruun, M.S., Dalsgaard, I., Larsen, J.L., 2007, The tetracycline resistance gene 
tet(E) is frequently occurring and present on large horizontally transferable plasmids 
in Aeromonas spp. from fish farms. Aquaculture 266, 47-52. 
Akinbowale, O.L., Peng, H., Barton, M.D., 2006, Antimicrobial resistance in bacteria 
isolated from aquaculture sources in Australia. J Appl Microbiol 100, 1103-1113. 
Alcaide, E., Blasco, M.D., Esteve, C., 2010, Mechanisms of quinolone resistance in 
Aeromonas species isolated from humans, water and eels. Res Microbiol 161, 40-
45. 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., 1990, Basic local 
alignment search tool. J Mol Biol 215, 403-410. 
Balassiano, I.T., Bastos Mdo, C., Madureira, D.J., Silva, I.G., Freitas-Almeida, A.C., 
Oliveira, S.S., 2007, The involvement of tetA and tetE tetracycline resistance genes 
in plasmid and chromosomal resistance of Aeromonas in Brazilian strains. Mem Inst 
Oswaldo Cruz 102, 861-866. 
Biyela, P.T., Lin, J., Bezuidenhout, C.C., 2004, The role of aquatic ecosystems as 
reservoirs of antibiotic resistant bacteria and antibiotic resistance genes. Water Sci 
Technol 50, 45-50. 
Bonnet, C., Diarrassouba, F., Brousseau, R., Masson, L., Topp, E., Diarra, M.S., 2009, 
Pathotype and antibiotic resistance gene distributions of Escherichia coli isolates 
from broiler chickens raised on antimicrobial-supplemented diets. Appl Environ 
Microbiol 75, 6955-6962. 
Carson, J., Wagner, T., Wilson, T., Donachie, L., 2001, Miniaturized tests for computer-
assisted identification of motile Aeromonas species with an improved probability 
matrix. J Appl Microbiol 90, 190-200. 
Castro-Escarpulli, G., Figueras, M.J., Aguilera-Arreola, G., Soler, L., Fernandez-Rendon, 
E., Aparicio, G.O., Guarro, J., Chacon, M.R., 2003, Characterisation of Aeromonas 
spp. isolated from frozen fish intended for human consumption in Mexico. Int J 
Food Microbiol 84, 41-49. 
Chang, Y.C., Shih, D.Y., Wang, J.Y., Yang, S.S., 2007, Molecular characterization of class 
1 integrons and antimicrobial resistance in Aeromonas strains from foodborne 
outbreak-suspect samples and environmental sources in Taiwan. Diagn Microbiol 
Infect Dis 59, 191-197. 
xliv 
 
 
Daskalov, H., 2006, The importance of Aeromonas hydrophila in food safety. Food Control 
17, 474-483. 
Davies, A.R., Capell, C., Jehanno, D., Nychas, G.J.E., Kirby, R.M., 2001, Incidence of 
foodborne pathogens on European fish. Food Control 12, 67-71. 
DePaola, A., Flynn, P.A., McPhearson, R.M., Levy, S.B., 1988, Phenotypic and genotypic 
characterization of tetracycline- and oxytetracycline-resistant Aeromonas 
hydrophila from cultured channel catfish (Ictalurus punctatus) and their 
environments. Appl Environ Microbiol 54, 1861-1863. 
Drancourt, M., Bollet, C., Carlioz, A., Martelin, R., Gayral, J.P., Raoult, D., 2000, 16S 
ribosomal DNA sequence analysis of a large collection of environmental and 
clinical unidentifiable bacterial isolates. J Clin Microbiol 38, 3623-3630. 
Falbo, V., Carattoli, A., Tosini, F., Pezzella, C., Dionisi, A.M., Luzzi, I., 1999, Antibiotic 
resistance conferred by a conjugative plasmid and a class I integron in Vibrio 
cholerae O1 El Tor strains isolated in Albania and Italy. Antimicrob Agents 
Chemother 43, 693-696. 
FAO 2010. The State of World Fisheries and Aquaculture 2010 (Rome, FAO Fisheries and 
aquaculture department). 
FAO/OIE/WHO 2006. Expert Consultation on Antimicrobial Use in Aquaculture and 
Antimicrobial Resistance (Seoul, Republic of Korea, World Health Organization). 
Furushita, M., Shiba, T., Maeda, T., Yahata, M., Kaneoka, A., Takahashi, Y., Torii, K., 
Hasegawa, T., Ohta, M., 2003, Similarity of tetracycline resistance genes isolated 
from fish farm bacteria to those from clinical isolates. Appl Environ Microbiol  69, 
5336-5342. 
Gay, K., Robicsek, A., Strahilevitz, J., Park, C.H., Jacoby, G., Barrett, T.J., Medalla, F., 
Chiller, T.M., Hooper, D.C., 2006, Plasmid-mediated quinolone resistance in non-
Typhi serotypes of Salmonella enterica. Clin Infect Dis 43, 297-304. 
Goni-Urriza, M., Arpin, C., Capdepuy, M., Dubois, V., Caumette, P., Quentin, C., 2002, 
Type II topoisomerase quinolone resistance-determining regions of Aeromonas 
caviae, A. hydrophila, and A. sobria complexes and mutations associated with 
quinolone resistance. Antimicrob Agents Chemother 46, 350-359. 
Goni-Urriza, M., Pineau, L., Capdepuy, M., Roques, C., Caumette, P., Quentin, C., 2000, 
Antimicrobial resistance of mesophilic Aeromonas spp. isolated from two European 
rivers. J Antimicrob Chemother 46, 297-301. 
xlv 
 
 
Hanninen, M.L., Oivanen, P., Hirvela-Koski, V., 1997, Aeromonas species in fish, fish-
eggs, shrimp and freshwater. Int J Food Microbiol 34, 17-26. 
Hsiao, C.T., Weng, H.H., Yuan, Y.D., Chen, C.T., Chen, I.C., 2008, Predictors of mortality 
in patients with necrotizing fasciitis. Am J Emerg Med 26, 170-175. 
Jacobs, L., Chenia, H.Y., 2007, Characterization of integrons and tetracycline resistance 
determinants in Aeromonas spp. isolated from South African aquaculture systems. 
Int J Food Microbiol 114, 295-306. 
Kaskhedikar, M., Chhabra, D., 2010, Multiple drug resistance in Aeromonas hydrophila 
isolates of fish. Veterinary World 32, 76-77. 
Kronvall, G., 2003, Determination of the real standard distribution of susceptible strains in 
zone histograms. Int J Antimicrob Agents 22, 7-13. 
Kronvall, G., Kahlmeter, G., Myhre, E., Galas, M.F., 2003, A new method for normalized 
interpretation of antimicrobial resistance from disk test results for comparative 
purposes. Clin Microbiol Infect 9, 120-132. 
Kruse, H., Sorum, H., 1994, Transfer of multiple drug resistance plasmids between bacteria 
of diverse origins in natural microenvironments. Appl Environ Microbiol  60, 4015-
4021. 
Kupfer, M., Kuhnert, P., Korczak, B.M., Peduzzi, R., Demarta, A., 2006, Genetic 
relationships of Aeromonas strains inferred from 16S rRNA, gyrB and rpoB gene 
sequences. Int J Syst Evol Microbiol 56, 2743-2751. 
Mazel, D., Dychinco, B., Webb, V.A., Davies, J., 2000, Antibiotic resistance in the ECOR 
collection: integrons and identification of a novel aad gene. Antimicrob Agents 
Chemother 44, 1568-1574. 
Novakova, D., Svec, P., Sedlacek, I., 2009, Characterization of Aeromonas encheleia 
strains isolated from aquatic environments in the Czech Republic. Lett Appl 
Microbiol 48, 289-294. 
Okuda, J., Hayakawa, E., Nishibuchi, M., Nishino, T., 1999, Sequence analysis of the gyrA 
and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its 
fluoroquinolone-resistant mutants. Antimicrob Agents Chemother 43, 1156-1162. 
Ormen, O., Granum, P.E., Lassen, J., Figueras, M.J., 2005, Lack of agreement between 
biochemical and genetic identification of Aeromonas spp. APMIS 113, 203-207. 
Radu, S., Ahmad, N., Ling, F.H., Reezal, A., 2003, Prevalence and resistance to antibiotics 
for Aeromonas species from retail fish in Malaysia. Int J Food Microbiol 81, 261-
xlvi 
 
 
266. 
Rosser, S.J., Young, H.K., 1999, Identification and characterization of class 1 integrons in 
bacteria from an aquatic environment. J Antimicrob Chemother 44, 11-18. 
Schmidt, A.S., Bruun, M.S., Dalsgaard, I., Larsen, J.L., 2001, Incidence, distribution, and 
spread of tetracycline resistance determinants and integron-associated antibiotic 
resistance genes among motile aeromonads from a fish farming environment. Appl 
Environ Microbiol 67, 5675-5682. 
Sorum, H., 2006, Antimicrobial drug resistance in fish pathogens, In:  Aarestrup, F.M. 
(Ed.) Antimicrobial resistance in bacteria of animal origin. ASM Press, Washington, 
D.C., pp. 213-238. 
Sorum, H., L'Abee-Lund, T.M., Solberg, A., Wold, A., 2003, Integron-containing IncU R 
plasmids pRAS1 and pAr-32 from the fish pathogen Aeromonas salmonicida. 
Antimicrob Agents Chemother 47, 1285-1290. 
Tuševljak, N., In-preparation, Antimicrobial use and resistance in aquaculture: Findings of 
a globally administered survey of aquaculture-allied professionals. 
Vivekanandhan, G., Savithamani, K., Hatha, A.A., Lakshmanaperumalsamy, P., 2002, 
Antibiotic resistance of Aeromonas hydrophila isolated from marketed fish and 
prawn of South India. Int J Food Microbiol 76, 165-168. 
Yucel, N., Balci, S., 2010, Prevalence of Listeria, Aeromonas, and Vibrio species in fish 
used for human consumption in Turkey. J Food Prot  73, 380-384. 
 
 
 
 
